

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in hepatic encephalopathy | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-1637/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-1637" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in hepatic encephalopathy" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in hepatic encephalopathy.">
            <meta name="og:description" content="Read the latest article version by Victoria Liere, Gurkarminder Sandhu, Sharon DeMorrow, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="12904">
            <meta name="article-id" content="11938">
            <meta name="dc.title" content="Recent advances in hepatic encephalopathy">
            <meta name="dc.description" content="Hepatic encephalopathy describes the array of neurological alterations that occur during acute liver failure or chronic liver injury. While key players in the pathogenesis of hepatic encephalopathy, such as increases in brain ammonia, alterations in neurosteroid levels, and neuroinflammation, have been identified, there is still a paucity in our knowledge of the precise pathogenic mechanism. This review gives a brief overview of our understanding of the pathogenesis of hepatic encephalopathy and then summarizes the significant recent advances made in clinical and basic research contributing to our understanding, diagnosis, and possible treatment of hepatic encephalopathy. A literature search using the PubMed database was conducted in May 2017 using &ldquo;hepatic encephalopathy&rdquo; as a keyword, and selected manuscripts were limited to those research articles published since May 2014. While the authors acknowledge that many significant advances have been made in the understanding of hepatic encephalopathy prior to May 2014, we have limited the scope of this review to the previous three years only.">
            <meta name="dc.subject" content="Hepatic encephalopathy, acute liver failure, chronic liver injury, neuroinflammation, pathogenesis">
            <meta name="dc.creator" content="Liere, Victoria">
            <meta name="dc.creator" content="Sandhu, Gurkarminder">
            <meta name="dc.creator" content="DeMorrow, Sharon">
            <meta name="dc.date" content="2017/09/04">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.11938.1">
            <meta name="dc.source" content="F1000Research 2017 6:1637">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Hepatic encephalopathy">
            <meta name="prism.keyword" content="acute liver failure">
            <meta name="prism.keyword" content="chronic liver injury">
            <meta name="prism.keyword" content="neuroinflammation">
            <meta name="prism.keyword" content="pathogenesis">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/09/04">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="1637">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.11938.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-1637">
            <meta name="citation_title" content="Recent advances in hepatic encephalopathy">
            <meta name="citation_abstract" content="Hepatic encephalopathy describes the array of neurological alterations that occur during acute liver failure or chronic liver injury. While key players in the pathogenesis of hepatic encephalopathy, such as increases in brain ammonia, alterations in neurosteroid levels, and neuroinflammation, have been identified, there is still a paucity in our knowledge of the precise pathogenic mechanism. This review gives a brief overview of our understanding of the pathogenesis of hepatic encephalopathy and then summarizes the significant recent advances made in clinical and basic research contributing to our understanding, diagnosis, and possible treatment of hepatic encephalopathy. A literature search using the PubMed database was conducted in May 2017 using &ldquo;hepatic encephalopathy&rdquo; as a keyword, and selected manuscripts were limited to those research articles published since May 2014. While the authors acknowledge that many significant advances have been made in the understanding of hepatic encephalopathy prior to May 2014, we have limited the scope of this review to the previous three years only.">
            <meta name="citation_description" content="Hepatic encephalopathy describes the array of neurological alterations that occur during acute liver failure or chronic liver injury. While key players in the pathogenesis of hepatic encephalopathy, such as increases in brain ammonia, alterations in neurosteroid levels, and neuroinflammation, have been identified, there is still a paucity in our knowledge of the precise pathogenic mechanism. This review gives a brief overview of our understanding of the pathogenesis of hepatic encephalopathy and then summarizes the significant recent advances made in clinical and basic research contributing to our understanding, diagnosis, and possible treatment of hepatic encephalopathy. A literature search using the PubMed database was conducted in May 2017 using &ldquo;hepatic encephalopathy&rdquo; as a keyword, and selected manuscripts were limited to those research articles published since May 2014. While the authors acknowledge that many significant advances have been made in the understanding of hepatic encephalopathy prior to May 2014, we have limited the scope of this review to the previous three years only.">
            <meta name="citation_keywords" content="Hepatic encephalopathy, acute liver failure, chronic liver injury, neuroinflammation, pathogenesis">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Victoria Liere">
            <meta name="citation_author_institution" content=" Department of Medical Physiology, College of Medicine, Texas A&amp;M Health Science Center, Temple, TX, USA">
            <meta name="citation_author" content="Gurkarminder Sandhu">
            <meta name="citation_author_institution" content="Department of Internal Medicine, Baylor Scott &amp; White, Temple, TX, USA">
            <meta name="citation_author" content="Sharon DeMorrow">
            <meta name="citation_author_institution" content=" Department of Medical Physiology, College of Medicine, Texas A&amp;M Health Science Center, Temple, TX, USA">
            <meta name="citation_author_institution" content="Central Texas Veterans Healthcare System, Temple, TX, USA">
            <meta name="citation_publication_date" content="2017/09/04">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="1637">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.11938.1">
            <meta name="citation_firstpage" content="1637">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-1637/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-1637.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=12904 /> <input type=hidden id=articleId name=articleId value=11938 /> <input type=hidden id=xmlUrl value="/articles/6-1637/v1/xml"/> <input type=hidden id=xmlFileName value="-6-1637-v1.xml"> <input type=hidden id=article_uuid value=2c54ef11-67be-419d-b440-3ced39e29ece /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in hepatic encephalopathy"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.11938.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.11938.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-1637"
  },
  "headline": "Recent advances in hepatic encephalopathy",
  "datePublished": "2017-09-04T14:41:46",
  "dateModified": "2017-09-04T14:41:46",
  "author": [
    {
      "@type": "Person",
      "name": "Victoria Liere"
    },    {
      "@type": "Person",
      "name": "Gurkarminder Sandhu"
    },    {
      "@type": "Person",
      "name": "Sharon DeMorrow"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Hepatic encephalopathy describes the array of neurological alterations that occur during acute liver failure or chronic liver injury. While key players in the pathogenesis of hepatic encephalopathy, such as increases in brain ammonia, alterations in neurosteroid levels, and neuroinflammation, have been identified, there is still a paucity in our knowledge of the precise pathogenic mechanism. This review gives a brief overview of our understanding of the pathogenesis of hepatic encephalopathy and then summarizes the significant recent advances made in clinical and basic research contributing to our understanding, diagnosis, and possible treatment of hepatic encephalopathy. A literature search using the PubMed database was conducted in May 2017 using &ldquo;hepatic encephalopathy&rdquo; as a keyword, and selected manuscripts were limited to those research articles published since May 2014. While the authors acknowledge that many significant advances have been made in the understanding of hepatic encephalopathy prior to May 2014, we have limited the scope of this review to the previous three years only."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-1637.html",
            "name": "Recent advances in hepatic encephalopathy"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in hepatic encephalopathy </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=12904 data-id=11938 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11938.1" data-recommended="" data-doi="10.12688/f1000research.11938.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-1637/v1/pdf?article_uuid=2c54ef11-67be-419d-b440-3ced39e29ece" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-11938-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-11938-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-11938-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Liere V, Sandhu G and DeMorrow S. Recent advances in hepatic encephalopathy [version 1; peer review: 4 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1637 (<a class=new-orange href="https://doi.org/10.12688/f1000research.11938.1" target=_blank>https://doi.org/10.12688/f1000research.11938.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-11938-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=11938 id=track-article-signin-11938 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11938?target=/articles/6-1637.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12904 /> <input name=articleId type=hidden value=11938 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in hepatic encephalopathy</h1><span class=other-info> [version 1; peer review: 4 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Victoria Liere<sup>1</sup><sup>*</sup>,&nbsp;</span><span class="">Gurkarminder Sandhu<sup>2</sup><sup>*</sup>,&nbsp;</span><span class=""><a href="mailto:demorrow@medicine.tamhsc.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Sharon DeMorrow</span></a><a href="https://orcid.org/0000-0002-0511-9778" target=_blank id=author-orcid-2><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-2><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-0511-9778</div><sup>1,3</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Victoria Liere<sup>1</sup><sup>*</sup>,&nbsp;</span><span class="">Gurkarminder Sandhu<sup>2</sup><sup>*</sup>,&nbsp;</span><span class=""><a href="mailto:demorrow@medicine.tamhsc.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Sharon DeMorrow</span></a><a href="http://orcid.org/0000-0002-0511-9778" target=_blank id=mauthor-orcid-2><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-2><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-0511-9778</div><sup>1,3</sup></span></div> </div> <div class="authors extra-info"> <sup>*</sup> Equal contributors </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 04 Sep 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.11938.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Medical Physiology, College of Medicine, Texas A&amp;M Health Science Center, Temple, TX, USA<br/> <sup>2</sup> Department of Internal Medicine, Baylor Scott &amp; White, Temple, TX, USA<br/> <sup>3</sup> Central Texas Veterans Healthcare System, Temple, TX, USA<br/> <p> <div class=margin-bottom> Victoria Liere <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Gurkarminder Sandhu <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Sharon DeMorrow <br/> <span>Roles: </span> Conceptualization, Funding Acquisition, Resources, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=25429-25325></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=5680-25327></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=25428-25326></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=25430-25324></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Hepatic encephalopathy describes the array of neurological alterations that occur during acute liver failure or chronic liver injury. While key players in the pathogenesis of hepatic encephalopathy, such as increases in brain ammonia, alterations in neurosteroid levels, and neuroinflammation, have been identified, there is still a paucity in our knowledge of the precise pathogenic mechanism. This review gives a brief overview of our understanding of the pathogenesis of hepatic encephalopathy and then summarizes the significant recent advances made in clinical and basic research contributing to our understanding, diagnosis, and possible treatment of hepatic encephalopathy. A literature search using the PubMed database was conducted in May 2017 using “hepatic encephalopathy” as a keyword, and selected manuscripts were limited to those research articles published since May 2014. While the authors acknowledge that many significant advances have been made in the understanding of hepatic encephalopathy prior to May 2014, we have limited the scope of this review to the previous three years only. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Hepatic encephalopathy, acute liver failure, chronic liver injury, neuroinflammation, pathogenesis </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Sharon DeMorrow (<a href="mailto:demorrow@medicine.tamhsc.edu">demorrow@medicine.tamhsc.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Sharon DeMorrow </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The authors declare that they have no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> This study was funded by an NIH R01 award (DK082435) and a VA Merit award (BX002638) from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service to Sharon DeMorrow. <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2017 Liere V <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Liere V, Sandhu G and DeMorrow S. Recent advances in hepatic encephalopathy [version 1; peer review: 4 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1637 (<a href="https://doi.org/10.12688/f1000research.11938.1" target=_blank>https://doi.org/10.12688/f1000research.11938.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 04 Sep 2017, <b>6</b>(F1000 Faculty Rev):1637 (<a href="https://doi.org/10.12688/f1000research.11938.1" target=_blank>https://doi.org/10.12688/f1000research.11938.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 04 Sep 2017, <b>6</b>(F1000 Faculty Rev):1637 (<a href="https://doi.org/10.12688/f1000research.11938.1" target=_blank>https://doi.org/10.12688/f1000research.11938.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d66598e190>Introduction</h2><p class="" id=d66598e193>Advanced liver disease is well known for its systemic consequences, notably its profound effects on brain function, in its most classic form, known as hepatic encephalopathy (HE). HE is currently defined as a brain dysfunction secondary to liver insufficiency and/or portosystemic shunting that manifests as a broad spectrum of neuropsychiatric abnormalities ranging from subclinical alterations to coma<sup><a href="#ref-1">1</a></sup>. It remains a diagnosis of exclusion<sup><a href="#ref-1">1</a></sup>. HE is frequent: overt HE is found in some 30–40% of patients with cirrhosis<sup><a href="#ref-1">1</a></sup>. In 2009, HE resulted in 22,931 hospitalizations with an average cost of each stay ranging from $46,663–$63,108<sup><a href="#ref-2">2</a></sup>. This highlights both the frequency of HE and the economic burden it currently places on the US.</p><p class="" id=d66598e212>The broad spectrum of HE has led to the development of multiple grading and classification systems to better categorize the severity of disease. It is currently a recommendation by the American Association for the Study of Liver Disease (AASLD) that HE should be classified according to the type of underlying disease, severity of manifestations, and precipitating factors<sup><a href="#ref-1">1</a></sup>. Types A, B, and C of HE define the underlying disease. Type A (acute) is due to acute liver failure (ALF), type B (bypass) is due to portosystemic shunting without intrinsic liver disease, and type C (cirrhosis) is due to cirrhosis<sup><a href="#ref-1">1</a></sup>. Each type has differing symptoms at presentation owing to the varying etiologies.</p><p class="" id=d66598e223>ALF, with the original term being fulminant hepatic failure, is defined as severe liver injury in the absence of pre-existing liver disease. The etiology of ALF is complex, ranging from viruses and drugs to genetic causes, with a vast majority remaining idiopathic<sup><a href="#ref-3">3</a></sup>. In developing nations, hepatitis (A, B, and C) is the most common cause of ALF, while in the US, acetaminophen toxicity accounts for 39% of ALF cases<sup><a href="#ref-3">3</a></sup>. Physical exam findings are often non-specific and generally reflect severe underlying liver dysfunction or complications thereof. ALF is currently a clinical diagnosis, made in the setting of acute liver injury in the context of abnormal liver tests (including dramatically elevated aminotransferases, and most importantly evidence of hepatocyte dysfunction demonstrated by a prolonged PT and increased INR<sup><a href="#ref-3">3</a></sup>). Unique to type A is its association with increased intracranial pressure (ICP), thus carrying a risk for cerebral herniation<sup><a href="#ref-1">1</a></sup>. It is believed that increased ICP results from cerebral edema secondary to hyperammonemia<sup><a href="#ref-3">3</a></sup>. One current proposed mechanism is that in ALF the development of hyperammonemia outpaces the compensatory mechanisms seen in chronic liver disease<sup><a href="#ref-3">3</a></sup>. Subsequently, ammonia increases intracellular osmolarity when it is metabolized to glutamine, resulting in cerebral edema causing increased ICP<sup><a href="#ref-3">3</a></sup>.</p><p class="" id=d66598e255>Type B HE is secondary to portosystemic bypass or bypass with no intrinsic hepatocellular disease. Precipitating factors of HE in type B are factors that are known to increase ammonia, such as azotemia, infection, GI bleed, lactulose noncompliance, and constipation<sup><a href="#ref-4">4</a></sup>. The most serious complication of transjugular intrahepatic portosystemic shunts (TIPS) is chronic recurrent HE that is refractory to standard treatment<sup><a href="#ref-4">4</a></sup>. If severe enough, shunt revision may be warranted<sup><a href="#ref-4">4</a></sup>.</p><p class="" id=d66598e271>Type C HE is associated with liver cirrhosis accompanied with either portal hypertension or portosystemic shunts<sup><a href="#ref-1">1</a></sup>. The causes of cirrhosis are vast, ranging from viral, autoimmune, chronic biliary disease, and fatty liver diseases to rare storage diseases such as hemochromatosis and Wilson’s disease<sup><a href="#ref-5">5</a></sup>. Signs and symptoms of cirrhosis are often present and include spider angioma, muscle wasting, jaundice, ascites, and gynecomastia and testicular atrophy in men. The most common form of HE in type C is minimal HE (MHE), which affects nearly 80% of cirrhotics<sup><a href="#ref-6">6</a></sup>. MHE affects the patient’s daily life, interfering with executive function including their working memory and orientation<sup><a href="#ref-6">6</a></sup>. Physical examination in MHE is often normal, and patients may present with subtle abnormalities that can be diagnosed by experts using specialized neurophysiologic tests, such as the critical flicker frequency test (CFF)<sup><a href="#ref-6">6</a></sup>. Currently, there is no gold standard test, and a number of studies are currently investigating the efficacy and use of them<sup><a href="#ref-7">7</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d66598e302>Pathophysiology</h2><p class="" id=d66598e305>As stated above, HE is broken into three major types because of its multiple etiologies. HE presents with a broad spectrum of symptoms ranging from subclinical to comatose. This wide range of presentation is due to the multifaceted pathophysiology that underlies this complex disease. Highlighted below is the role of ammonia and inflammation in the development of HE.</p><p class="" id=d66598e308>Currently, ammonia is the best-characterized neurotoxin in the pathogenesis of HE and also appears to be important in the genesis of astrocyte swelling<sup><a href="#ref-8">8</a></sup>. In healthy individuals, nitrogenous compounds, such as proteins, are metabolized by gut microflora and transported to the liver in the form of ammonia<sup><a href="#ref-8">8</a></sup>. In the liver, ammonia is metabolized by the urea cycle with the majority of the subsequent urea excreted renally<sup><a href="#ref-8">8</a></sup>. Advanced liver disease or portosystemic shunting leads to a buildup of ammonia in the blood<sup><a href="#ref-8">8</a></sup>. Ammonia that builds up in the blood is then able to cross the blood–brain barrier, where it is metabolized by astrocytes into glutamine<sup><a href="#ref-8">8</a></sup>. Hence, levels of glutamine start to accumulate and lead to astrocyte swelling. This swelling can trigger a downward spiral leading to increase in production of reactive oxygen and nitrogen species, which can downstream target gene transcription and translation<sup><a href="#ref-9">9</a></sup>. Animal models of HE emphasize that astrocyte and brain swelling is also a key feature. Among these features are swelling of astrocytes, vasoconstriction of blood vessels, increase in ICP, cerebral edema, reduced cerebral perfusion, and cerebral atrophy<sup><a href="#ref-9">9</a></sup>. There are conflicting studies regarding the correlation of levels of ammonia and the degree of encephalopathy; however, evidence suggests that a reduction in levels of ammonia leads to reduced brain swelling<sup><a href="#ref-9">9</a></sup>.</p><p class="" id=d66598e344>In addition to the ammonia hypothesis, inflammation and cytokines are thought to be major components in the development of HE, particularly in the setting of ALF with or without sepsis<sup><a href="#ref-10">10</a></sup>. Septic encephalopathy is a well-documented phenomenon that closely resembles HE<sup><a href="#ref-10">10</a></sup>. Although sepsis and ALF have varied pathogenic mechanisms, they share the same cardinal features of encephalopathy, cardiovascular collapse, and coagulopathy<sup><a href="#ref-10">10</a></sup>. Both sepsis and ALF result in an upregulation of inflammatory cytokines IL-1β, IL-6, and TNF-α<sup><a href="#ref-10">10</a></sup>. Studies have shown that these inflammatory cytokines compromise the blood–brain barrier and disrupt the permeability of the endothelial cells<sup><a href="#ref-10">10</a></sup>. It is not surprising that sepsis can precipitate and worsen HE<sup><a href="#ref-10">10</a></sup>. Cytokines, infection, and inflammation play a significant role in the development of HE. Studies have implicated both ammonia and inflammation in the pathogenesis of HE<sup><a href="#ref-10">10</a></sup>. Currently, it is proposed that these pathways have a synergistic effect on each other<sup><a href="#ref-10">10</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d66598e383>Recent advances in understanding the pathogenesis of hepatic encephalopathy</h2><p class="" id=d66598e386>Recent advances in the understanding of the pathogenesis of HE focus on the consequences of hyperammonemia and altered neurotransmission, and new studies have aimed to examine new potential targets such as bile acid signaling and their contribution to HE. Below is a summary of the latest findings (see also <a href="#f1">Figure 1</a>).</p><div class="fig panel clearfix"><a name=f1 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/12904/5611add8-7806-413b-8ae1-94357b4e110e_figure1.gif"><img alt="5611add8-7806-413b-8ae1-94357b4e110e_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/12904/5611add8-7806-413b-8ae1-94357b4e110e_figure1.gif"></a><div class=caption><h3>Figure 1. Summary of all factors known to contribute to the pathogenesis of hepatic encephalopathy.</h3></div></div><div class=section><a name=d66598e406 class=n-a></a><h3 class=section-title>Hyperammonemia</h3><p class="" id=d66598e411>A major contributing factor to the development of HE is a buildup of ammonia. Liver-specific glutamine synthetase knockout (a key enzyme in ammonia metabolism) led to dramatically increased systemic hyperammonemia and subsequent cerebral oxidative stress and cognitive changes<sup><a href="#ref-11">11</a></sup>, consistent with the concept that the liver is integral in the maintenance of ammonia homeostasis throughout the body.</p><p class="" id=d66598e418>In the brain under hyperammonemic conditions, astrocytes rapidly convert blood-derived ammonia into glutamine, increasing glutamine levels<sup><a href="#ref-12">12</a></sup>. An understanding of the full array of consequences of hyperammonemia on astrocytic function in the context of HE is, as yet, unappreciated. Historically, it was thought that the effects of increased cerebral ammonia were increased oxidative stress, osmotic pressure, and subsequent astrocyte swelling. However, recent studies have demonstrated that ammonia also has effects on many signal transduction pathways<sup><a href="#ref-13">13</a>–<a href="#ref-15">15</a></sup>, gene expression<sup><a href="#ref-16">16</a></sup>, and post-translational protein modifications<sup><a href="#ref-17">17</a></sup>, which together lead to subsequent impairment in astrocyte function and manifest as abnormal proliferation<sup><a href="#ref-18">18</a>,<a href="#ref-19">19</a></sup>, neurotransmitter release<sup><a href="#ref-16">16</a></sup>, and even cellular senescence<sup><a href="#ref-18">18</a></sup>. For example, hyperammonemia was recently associated with a transient increase in astrocyte intracellular calcium release<sup><a href="#ref-13">13</a>–<a href="#ref-15">15</a></sup>; the precise mechanism of action may be through activation of NMDA receptor<sup><a href="#ref-13">13</a></sup>, the transient receptor potential channel 1<sup><a href="#ref-14">14</a></sup>, or the Cav1.2 L-type calcium channel<sup><a href="#ref-15">15</a></sup>, or, more likely, a combination of all of the above. Given that calcium-mediated effects are an early event of many different signal transduction pathways, the vast array of potential gene expression alterations due to hyperammonemia has not yet been defined.</p><p class="" id=d66598e475>A relatively novel mechanism by which ammonia may influence gene expression is via alterations in microRNA expression. MicroRNAs are small non-coding RNA sequences that play a role in gene silencing at the level of gene transcription as well as translation and can be regulated by oxidative stress. Exposure of astrocytes to ammonia dramatically altered microRNA profiles<sup><a href="#ref-19">19</a></sup>, leading to an alteration in many target genes, including heme oxygenase 1. Preventing ammonia-induced microRNA expression changes increased the expression of heme oxygenase 1 and prevented the ammonia-induced inhibition of astrocyte proliferation and prevented the associated cellular senescence<sup><a href="#ref-19">19</a></sup>.</p><p class="" id=d66598e486>Lastly, though not surprisingly, ammonia has been shown to alter the expression of genes involved in the regulation of astrocytic glutamate uptake and neurotransmitter release, such as the ephrin receptors and their ligands<sup><a href="#ref-16">16</a></sup> and thrombospondin 1<sup><a href="#ref-20">20</a></sup>. Specifically, the treatment of astrocytes in culture with ammonia increased ephrin receptor 4 via an as-yet-undefined pathway that includes glutamine synthetase, NADPH oxidase, and nitric oxide synthase activities<sup><a href="#ref-16">16</a></sup>. Conversely, chronic ammonia treatment decreased thrombospondin 1 expression in astrocytes, which subsequently decreased the expression of synaptic proteins in neurons<sup><a href="#ref-20">20</a></sup>.</p><p class="" id=d66598e506>Ammonia may also contribute to the cell-to-cell crosstalk that occurs in HE. Specifically, the treatment of brain endothelial cells with ammonia, a mixture of cytokines, or lipopolysaccharide appeared to release factors that contribute to astrocyte swelling via the activation of Toll-like receptor 4<sup><a href="#ref-21">21</a></sup>. The understanding of cell–cell interactions and communication and the role of ammonia in HE is still quite limited. In further support of the notion that cell–cell communication is involved in ammonia-induced events during HE, strategies to uncouple the gap junctions in astrocyte cultures significantly attenuated key features of ammonia-induced neurotoxicity, such as membrane integrity, oxidative stress, and pro-inflammatory cytokine release<sup><a href="#ref-22">22</a></sup>.</p></div><div class=section><a name=d66598e518 class=n-a></a><h3 class=section-title>Oxidative stress</h3><p class="" id=d66598e523>Oxidative stress and the generation of reactive oxygen and nitrogen species in the brain has long been associated with HE. It is thought that impaired mitochondrial function and downregulation of the expression of key anti-oxidation enzymes contribute to an increase in oxidative damage to membrane lipids, protein, and DNA<sup><a href="#ref-23">23</a></sup>.</p><p class="" id=d66598e530>Recent studies have emphasized the importance of oxidative damage in the pathogenesis of HE, with various experimental treatments aimed at reducing reactive oxygen/nitrogen species<sup><a href="#ref-24">24</a>–<a href="#ref-31">31</a></sup> or restoring the activity of anti-oxidative enzymes such as catalase<sup><a href="#ref-32">32</a></sup>, superoxide dismutase<sup><a href="#ref-32">32</a></sup>, thioredoxin<sup><a href="#ref-25">25</a></sup>, or glutathione peroxidase<sup><a href="#ref-25">25</a></sup>. Of particular note was an elegant study by Bosoi <i>et al</i>.<sup><a href="#ref-33">33</a></sup>, in which the authors utilized a rodent model of hyperammonemia that was also treated with an inhibitor of glutathione; they found that a synergistic relationship between systemic oxidative stress and hyperammonemia was required for the development of brain edema in HE<sup><a href="#ref-33">33</a></sup>.</p></div><div class=section><a name=d66598e570 class=n-a></a><h3 class=section-title>Brain energy metabolism</h3><p class="" id=d66598e575>The pathogenesis of HE has long been associated with impairment in cerebral energy metabolism with alterations in glucose utilization, glycolysis, and mitochondrial dysfunction (reviewed in Rama Rao and Norenberg<sup><a href="#ref-34">34</a></sup>). Of particular interest are the changes in cerebral lactate levels during HE. Specifically, increased blood and cerebral lactate levels have been demonstrated in patients with HE<sup><a href="#ref-35">35</a></sup>, in pig and rodent models of ALF<sup><a href="#ref-36">36</a>,<a href="#ref-37">37</a></sup>, and in acute hyperammonemia<sup><a href="#ref-38">38</a></sup>. However, the increase in cerebral lactate in models of type C HE is not as clear-cut. Increased lactate has been observed in the plasma of patients with cirrhosis compared to age- and sex-matched controls<sup><a href="#ref-39">39</a></sup>. Interestingly, there was no significant difference in plasma lactate levels between cirrhotic patients who exhibit symptoms of overt HE versus patients without overt HE, although the presence of MHE in the latter group could not be ruled out<sup><a href="#ref-39">39</a></sup>. A parallel change in lactate levels in the brain was not evident in a longitudinal study using 1H and 31P magnetic resonance spectroscopy in a rodent model of type C HE<sup><a href="#ref-12">12</a></sup>. Conversely, <i>de novo</i> synthesis of lactate was increased in the brain, and treatment with a lactate synthesis inhibitor attenuated HE-associated brain edema in this model<sup><a href="#ref-40">40</a></sup>. This disparity between these two opposing observations may lie in the methodology used to detect the differences. However, recently, it was demonstrated that the transport of lactate through connexin-containing hemichannels in astrocytes was impaired in the cerebral cortices of rats with type C HE owing, at least in part, to the actions of hyperammonemia<sup><a href="#ref-41">41</a></sup>. Given that the astrocyte–neuron lactate shuttle hypothesis suggests that lactate production in astrocytes is able to fuel and regulate neuronal activity<sup><a href="#ref-42">42</a></sup>, it was hypothesized that the impairment of lactate transport through hemichannels may be contributing to the pathogenesis of HE<sup><a href="#ref-41">41</a></sup>.</p></div><div class=section><a name=d66598e631 class=n-a></a><h3 class=section-title>Neuroinflammation</h3><p class="" id=d66598e636>Brain inflammation (i.e. “neuroinflammation”) is a key feature in common with all types of HE and appears to be predominantly modulated by microglia, the resident macrophage-like cell in the brain. Indirect clinical evidence for microglial activation has been demonstrated by an upregulation of the microglial marker ionized calcium-binding adaptor molecule 1 (Iba-1), which was found to be increased in post mortem cortical brain tissue from patients with liver cirrhosis and HE compared to cirrhotic patients without HE<sup><a href="#ref-43">43</a></sup>. In addition, a comprehensive gene expression profile analysis showed that markers for both the pro-inflammatory M1 and the anti-inflammatory M2 microglial phenotypes were increased, suggesting that both groups can be found in patients with HE caused by cirrhosis<sup><a href="#ref-44">44</a></sup>.</p><p class="" id=d66598e647>The activation of microglia is a delicate balance between the pro-inflammatory and anti-inflammatory signals, which in physiological conditions favors the dampening of microglia activation<sup><a href="#ref-45">45</a></sup>. These signals may be derived from the microglia themselves or are as a result of cell-to-cell communication derived from neurons or astrocytes. Recently, the pro-inflammatory chemokine CCL2 was demonstrated to be increased in neurons in a mouse model of type A HE<sup><a href="#ref-46">46</a></sup> and a concomitant decrease in the anti-inflammatory chemokine fractalkine<sup><a href="#ref-45">45</a></sup>, thereby dysregulating the balance between opposing pro- and anti-inflammatory signals acting on receptors on microglia resulting in microglia activation. Strategies to either block CCL2 receptors or increase fractalkine signaling inhibited the microglia activation and attenuated the cognitive dysfunction observed in this model of HE, although the precise mechanism by which the balance between these two opposing signals is dysregulated was not identified.</p><p class="" id=d66598e662>Interestingly, in the hyperammonemic rat model, microglia and astrocytes were activated with a concomitant increase in the expression of pro-inflammatory cytokines IL-1β and IL-6<sup><a href="#ref-47">47</a></sup>, suggesting that ammonia alone is capable of inducing neuroinflammation during HE, although it is unlikely that the modulation of neuroinflammation is solely the consequence of hyperammonemia during HE.</p><p class="" id=d66598e669>Evidence to suggest a causal link between neuroinflammation and cognitive and motor function impairment during HE is mounting. Strategies that specifically target and dampen the neuroinflammatory signals also offer attenuation of cognitive and motor deficits<sup><a href="#ref-46">46</a>,<a href="#ref-48">48</a>–<a href="#ref-52">52</a></sup>, although care should be taken when interpreting data from experiments where the anti-inflammatory experimental agent is given systemically, as the mechanism of action may be via hepato-protection, thereby leading to a reduction in HE symptoms rather than as a direct modulatory effect on central neuroinflammation. While treatment strategies aimed at dampening systemic inflammation may be beneficial for both the underlying liver damage and the subsequent encephalopathy, from a basic science standpoint aimed at elucidating the pathogenic pathways associated with the development of HE, the distinction between the actions of an experimental compound on the brain versus its actions on the liver should be distinguished.</p></div><div class=section><a name=d66598e683 class=n-a></a><h3 class=section-title>Neurotransmitter dysfunction</h3><p class="" id=d66598e688>The cognitive and neuromuscular deficits observed during HE are ultimately the result of altered neurotransmission, regardless of the mechanism<sup><a href="#ref-53">53</a></sup>. Interestingly, there are opposing effects on glutamatergic neurotransmission depending upon the type of HE with increased extracellular glutamate levels observed after ALF, and a dampened glutamatergic neurotransmission observed during chronic liver disease<sup><a href="#ref-53">53</a></sup>. During ALF, the activation of NMDA receptors on astrocytes downregulates the expression of Kir4.1, an inward rectifying potassium channel known to regulate ion and water homeostasis<sup><a href="#ref-54">54</a></sup> and contribute to neuronal dysfunction in other neurodegenerative diseases<sup><a href="#ref-55">55</a></sup>. The precise role for Kir4.1 in type A HE is not clear. Furthermore, strategies to block NMDA receptors in rats with ALF reduced the HE-associated changes in cerebral blood flow and brain lactate as well as increased the kidney clearance of ammonia, which collectively delayed or prevented the HE-associated mortality<sup><a href="#ref-56">56</a></sup>. Conversely, during MHE due to chronic liver disease, memory impairment was associated with suppression of the glutamate–nitric oxide–cyclic guanosine monophosphate (GMP) pathway, which has been demonstrated in response to hyperammonemia<sup><a href="#ref-57">57</a></sup> or increased intracranial dopamine<sup><a href="#ref-58">58</a></sup>, and strategies to restore this pathway also restore the learning ability of rats with HE<sup><a href="#ref-57">57</a></sup>.</p><p class="" id=d66598e724>Both type A and type C HE are associated with increased GABA-ergic tone. This is due to a number of factors: increased GABA concentrations<sup><a href="#ref-59">59</a></sup>, increased GABA receptor expression<sup><a href="#ref-59">59</a></sup>, and increased neurosteroids such as allopregnanolone, known to regulate GABA-ergic neurotransmission<sup><a href="#ref-60">60</a></sup>. Neurosteroids are steroids produced <i>de novo</i> in the brain<sup><a href="#ref-61">61</a></sup>. Their production and function are currently under investigation. Recently, experimental compounds aimed at either inhibiting neurosteroid synthesis<sup><a href="#ref-62">62</a></sup> or inhibiting the enhanced activation of GABAA receptors by neurosteroids<sup><a href="#ref-63">63</a></sup> attenuated the deficits in motor co-ordination, spatial memory, and circadian rhythms observed during HE<sup><a href="#ref-62">62</a>,<a href="#ref-63">63</a></sup>. These data were supported by the use of an inhibitor of another neurotransmitter system thought to be dysregulated during at least MHE: the dopamine system<sup><a href="#ref-64">64</a></sup>. However, how this system is altered during HE remains unclear. It has been hypothesized that an increase in dopamine release from cirrhotic liver into the bloodstream contributes to the pathogenic features of MHE by inhibiting the glutamate–nitric oxide–cyclic GMP pathway in the hippocampus, thereby altering learning and memory ability<sup><a href="#ref-58">58</a>,<a href="#ref-64">64</a>–<a href="#ref-66">66</a></sup>. Conversely, dopamine and serotonin levels were decreased in another model of MHE<sup><a href="#ref-67">67</a></sup>.</p></div><div class=section><a name=d66598e781 class=n-a></a><h3 class=section-title>Bile acids</h3><p class="" id=d66598e786>Elevated circulating and cranial levels of bile acids have been observed in patients with HE as early as 1977, although our understanding of the implications of this observation are only just coming to light. Specifically, total bile acid content in the cerebrospinal fluid as well as in brain tissue was elevated in patients and rodent models of type A HE<sup><a href="#ref-68">68</a>,<a href="#ref-69">69</a></sup> as well as type C HE<sup><a href="#ref-70">70</a>–<a href="#ref-72">72</a></sup>; however, the precise role of bile acids in HE remains controversial. Increased serum bile acids have been implicated in the increased blood–brain barrier permeability observed in a rat model of chronic liver disease<sup><a href="#ref-70">70</a></sup>, thereby allowing access of bile acids and other signaling molecules to the brain. In mice, azoxymethane (AOM) is used as a model for type A HE due to ALF<sup><a href="#ref-69">69</a></sup>. Indeed, in the AOM mouse model of type A HE, increased total bile acid content was observed in the frontal cortex, and strategies to reduce circulating bile acids (e.g. cholestyramine feeding or the use of a genetically modified mouse with impaired bile acid synthesis) proved neuroprotective<sup><a href="#ref-69">69</a></sup>.</p><p class="" id=d66598e815>Bile acids can exert their effects via many different receptors that result in an array of physiological responses. FXR is a nuclear bile acid receptor, and inhibition of FXR-mediated signaling in the frontal cortex conferred partial protection against the cognitive deficit that occurs during HE<sup><a href="#ref-69">69</a></sup>. Furthermore, aberrant bile acid signaling in the brain can also affect neuroinflammation by increasing pro-inflammatory CCL2 expression in neurons via a sphingosine-1-phosphate receptor 2-dependent mechanism, which subsequently leads to the activation of microglia and increase in pro-inflammatory cytokine expression<sup><a href="#ref-73">73</a></sup>. Conversely, TGR5 is a membrane-bound G-protein-coupled bile acid receptor, the expression of which has been shown to decrease in the brain in conditions of hyperammonemia<sup><a href="#ref-74">74</a></sup>. Activation of this receptor with specific agonists reduced the microglia activation and pro-inflammatory cytokine production observed in a mouse model of type A HE<sup><a href="#ref-75">75</a></sup>.</p><p class="" id=d66598e834>Many therapeutic strategies to treat HE, such as lactulose and metronidazole, abolish gut microbiota with the aim of reducing ammonia production while also influencing the conjugation of secondary bile acids. By altering the bile acid pool, they generate protective effects by altering bile acid signaling. In support of this notion, feeding mice a diet enriched in particular bile acids, which does not alter the total bile acid pool but alters the balance of individual bile acids, changed the susceptibility of mice to the development of HE<sup><a href="#ref-69">69</a></sup>. Specifically, mice fed a diet enriched with deoxycholic acid or cholic acid had significantly quicker neurological decline compared to control-fed or ursodeoxycholic acid-fed mice<sup><a href="#ref-69">69</a></sup>. These data raise the possibility that the elevation of cranial bile acids as well as a change in specific bile acids in the bile acid pool contribute to the neurological decline associated with HE; further clinical studies that manipulate bile acids are necessary to determine whether these effects will be recapitulated in patients with HE.</p></div><div class=section><a name=d66598e846 class=n-a></a><h3 class=section-title>Blood–brain barrier permeability</h3><p class="" id=d66598e851>The role of blood–brain barrier permeability is controversial in HE. No robust evidence of its breakdown exists; however, it is highly likely that bile acids and pro-inflammatory cytokines may affect its permeability<sup><a href="#ref-70">70</a>,<a href="#ref-76">76</a>–<a href="#ref-79">79</a></sup>. In the AOM model of type A HE, permeability of the blood–brain barrier has been demonstrated as a late event during the development of HE<sup><a href="#ref-78">78</a>,<a href="#ref-79">79</a></sup>. Conversely, no changes in permeability could be detected by another group unless the mice were co-treated with trace amounts of lipopolysaccharide<sup><a href="#ref-80">80</a></sup>, suggesting a synergistic role for inflammation with other key HE-related features in the changes in blood–brain barrier permeability. Consistent with this notion was a study demonstrating that circulating transforming growth factor-β (TGFβ) may contribute to the increased permeability of the blood–brain barrier in ALF<sup><a href="#ref-78">78</a></sup>.</p><p class="" id=d66598e879>Evidence to suggest that blood–brain barrier permeability is increased in type C HE also exists. As stated above, increased permeability in the bile duct ligation model of HE is apparent and can be attributed, at least in part, to increased serum bile acids<sup><a href="#ref-70">70</a></sup>. Associated with this increased permeability was a decrease in expression of tight junction proteins<sup><a href="#ref-76">76</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d66598e894>Recent advances in the diagnosis of hepatic encephalopathy</h2><p class="" id=d66598e897>HE remains a diagnosis of exclusion with a broad spectrum of clinical manifestations. The multifaceted presentation poses many limitations to the diagnosis of HE. Guidelines by the AASLD emphasize the use of specialized psychometric tests in the diagnosis of HE<sup><a href="#ref-81">81</a>–<a href="#ref-83">83</a></sup>. A multitude of tests exist, with some of the most studied being the psychomotor hepatic encephalopathy score (PHES), CFF, Stroop effect test, and electroencephalogram (EEG)<sup><a href="#ref-81">81</a>,<a href="#ref-84">84</a></sup>.</p><p class="" id=d66598e914>PHES is a battery of pencil and paper tests aimed at diagnosing HE<sup><a href="#ref-85">85</a></sup>. PHES was studied in Turkey and Romania in order to standardize a normal value in a healthy population and also assess its utility<sup><a href="#ref-85">85</a>,<a href="#ref-86">86</a></sup>. Age and educational status were shown to affect score<sup><a href="#ref-85">85</a></sup>.</p><p class="" id=d66598e932>Apart from PHES, a newly developed electronic number connection test (eNCT) was investigated by Wuensh <i>et al</i>.<sup><a href="#ref-87">87</a></sup>. This test flashes the numbers 1–25 on a screen and requires the participant to click them in order while being timed; those patients with HE were found to be much slower<sup><a href="#ref-87">87</a></sup>. This test promises to be an easier and faster method than PHES<sup><a href="#ref-87">87</a></sup>.</p><p class="" id=d66598e950>In the CFF, patients are shown a light flicker that progressively decreases in frequency<sup><a href="#ref-88">88</a></sup>. They must identify the frequency at which the light flickers<sup><a href="#ref-88">88</a></sup>. CFF can be used as a measure of cortical function and the diagnosis of HE<sup><a href="#ref-88">88</a></sup>. Studies show that with a cut-off value of &lt;39 Hz, CFF has a sensitivity of 39%, specificity of 82%, and diagnostic accuracy of 70.6% for MHE<sup><a href="#ref-82">82</a>,<a href="#ref-88">88</a></sup>. CFF is an important and simple tool for diagnosis and should be combined with the model for end stage liver disease (MELD) score for better diagnosis<sup><a href="#ref-89">89</a></sup>. MELD is a scoring system used to grade the severity of liver disease<sup><a href="#ref-90">90</a></sup>.</p><p class="" id=d66598e982>A prospective study of 117 consecutive patients with cirrhosis examined the administration of the CFF to detect HE<sup><a href="#ref-91">91</a></sup>. The authors found that MHE was associated with a reduced 5-year survival rate in patients with cirrhosis<sup><a href="#ref-91">91</a></sup>. CFF could be used in the future to improve the accuracy of prognosis in patients with cirrhosis<sup><a href="#ref-91">91</a></sup>.</p><p class="" id=d66598e997>Another study focused on Stroop testing, which tests psychomotor speed, attention, and cognitive flexibility<sup><a href="#ref-92">92</a></sup> in the form of an app coined EncephalApp. The app’s reliability was tested compared to the gold standard tests and was validated by multicenter and multi-national analysis in the USA with over 800 subjects<sup><a href="#ref-92">92</a></sup>. Another validation of the EncephalApp was done with 437 cirrhotics and 308 controls, and it was compared with PHES and the inhibitory control test (ICT)<sup><a href="#ref-93">93</a></sup>. When compared against the controls, the app was found to be equivalent in predicting HE, thus proving to be a convenient and validated method for the diagnosis of HE<sup><a href="#ref-93">93</a></sup>.</p><p class="" id=d66598e1016>Currently, the analysis of EEG patterns in children is used for grading HE in ALF<sup><a href="#ref-94">94</a></sup>. Nonetheless, EEG use in HE remains controversial. One study recorded EEGs in 69 healthy controls and 113 adults with cirrhosis<sup><a href="#ref-95">95</a></sup>. New spectral thresholds were calculated and optimized the performance of EEG for the diagnosis of HE<sup><a href="#ref-95">95</a></sup>. Though improvements were made in the use of EEG for the diagnosis of HE, validation is needed along with further research to understand the pathophysiological mechanism behind the EEG changes<sup><a href="#ref-95">95</a>–<a href="#ref-97">97</a></sup>.</p><p class="" id=d66598e1038>Key changes in brain function have been studied with functional magnetic resonance imaging (MRI)<sup><a href="#ref-98">98</a></sup> in combination with arterial-spin labeling to enhance the detection of HE<sup><a href="#ref-99">99</a></sup>. Connectivity status between 90 brain regions was assessed by measuring blood flow. HE showed impairment in the ganglia–thalamo–cortical circuits, with increased blood flow in the right putamen<sup><a href="#ref-99">99</a></sup>.</p><p class="" id=d66598e1053>Acknowledging the multiple etiologies of HE, researchers investigated if the cause of HE affected its presentation on imaging. Neurocognitive, biochemical, and brain MRI changes have been examined in patients with cirrhotic HE and extrahepatic portal vein obstruction (EHPVO) HE<sup><a href="#ref-100">100</a></sup>. Serum studies showed no change in ammonia levels while cytokine levels were higher in cirrhotic HE<sup><a href="#ref-100">100</a></sup>. Cirrhotic HE showed imaging changes that were absent in EHPVO HE<sup><a href="#ref-100">100</a></sup>. Cirrhotic HE affected multiple brain sites ranging from the frontal lobe all the way to the brainstem<sup><a href="#ref-100">100</a></sup>.</p><p class="" id=d66598e1072>Spontaneous brain activity can also be measured by examining the amplitude of low-frequency fluctuation (ALFF) in the MRI<sup><a href="#ref-101">101</a></sup>. It can be used as a biomarker for the detection of HE<sup><a href="#ref-101">101</a></sup>. Upcoming research focuses on ALFF in combination with blood oxygenation level-dependent functional MRI, creating new opportunities for the diagnosis of HE<sup><a href="#ref-102">102</a></sup>.</p><p class="" id=d66598e1088>Cerebral blood flow is altered in HE. Regional cerebral blood flow was studied by comparing dogs with congenital portosystemic shunt with HE to controls using nuclear imaging<sup><a href="#ref-103">103</a></sup>. It showed decreased perfusion of subcortical and temporal regions in dogs with HE<sup><a href="#ref-103">103</a></sup>. This highlights the role that nuclear imaging, specifically single photon emission computed tomography, can play in helping diagnose HE<sup><a href="#ref-103">103</a></sup>.</p><p class="" id=d66598e1103>Metabolic profiling analyzes body fluids or tissues by measuring low-molecular-weight compounds using either <sup>1</sup>H-NMR spectroscopy or mass spectrometry techniques<sup><a href="#ref-104">104</a></sup>. Currently, it is used in hepatocellular carcinoma; however, its use in HE had not been previously studied<sup><a href="#ref-104">104</a></sup>. Studies have shown that metabolic profiling can distinguish overt HE, but it cannot discriminate between differing grades of HE or according to the severity of underlying liver disease<sup><a href="#ref-104">104</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d66598e1124>Recent research on the treatment of hepatic encephalopathy</h2><div class=section><a name=d66598e1127 class=n-a></a><h3 class=section-title>Gut microbiome</h3><p class="" id=d66598e1132>The gut microbiome is implicated in the pathogenesis of HE<sup><a href="#ref-105">105</a>–<a href="#ref-108">108</a></sup>. Urease-producing bacteria predominantly lead to elevated levels of ammonia and serve as a target for many treatments<sup><a href="#ref-109">109</a></sup>. A cross-sectional study set out to determine the species of gut microbiota predominant in HE and suggested that an absence of <i>Blastocystis</i> spp. led to dysbiosis.</p><p class="" id=d66598e1149>Proton pump inhibitors (PPIs), a major treatment for gastroesophageal reflux, have been shown to be related to HE<sup><a href="#ref-110">110</a>–<a href="#ref-112">112</a></sup>. While the exact mechanism underlying this association is not known, it is currently thought to be due to alterations in the gut microbiome. PPIs have a known association with gut dysbiosis<sup><a href="#ref-110">110</a>–<a href="#ref-112">112</a></sup>. A case-control study of one million people in Taiwan followed for an average of nearly 14 years demonstrated that in patients with both cirrhosis and HE, 38% used a PPI<sup><a href="#ref-112">112</a></sup>; all categories of PPIs, except rabeprazole, led to an increased risk of HE<sup><a href="#ref-112">112</a></sup>. It is crucial to recognize the irreversible consequences that can occur with non-specific selection of treatment for reflux. Likewise, a meta-analysis showed that those with liver dysfunction who took a PPI had a higher risk of developing HE compared to those who did not take a PPI<sup><a href="#ref-110">110</a></sup>.</p><p class="" id=d66598e1178>Recognizing the importance of the gut microbiome hypotheses has led to study of the role of probiotics in HE<sup><a href="#ref-113">113</a>,<a href="#ref-114">114</a></sup>. A meta-analysis of randomized trials suggested that probiotics are more effective in decreasing hospitalization rates, improving MHE, and preventing progression to overt HE<sup><a href="#ref-115">115</a></sup>. Similarly, a further meta-analysis by the Cochrane collaboration revealed that when compared to placebo, probiotics mildly improved recovery, decreased overt HE, improved quality of life, and mildly decreased plasma ammonia<sup><a href="#ref-116">116</a>–<a href="#ref-118">118</a></sup>. Of note, probiotics have no effect on mortality<sup><a href="#ref-116">116</a>–<a href="#ref-118">118</a></sup>. Because of the low quality of evidence, no direct conclusions can be made, as more research is needed<sup><a href="#ref-116">116</a>–<a href="#ref-118">118</a></sup>. A double-blind randomized placebo-controlled clinical trial studied the effectiveness of VSL#3<sup><a href="#ref-119">119</a></sup> in Chandigarh, India. This study demonstrated reductions in hospitalizations and severity of breakthrough episodes of HE as well as improvement in PHES and liver function in patients receiving VSL#3<sup><a href="#ref-119">119</a></sup>.</p><p class="" id=d66598e1222>Diet changes have been studied to determine their effects on cognitive function in patients with MHE with cirrhosis<sup><a href="#ref-120">120</a></sup>. One study in 2016 compared patients prescribed a diet with a caloric restriction of 30–35 kcal/kg and a protein intake of 1.0–1.5 g of vegetable protein/kg to a control group for six months<sup><a href="#ref-120">120</a></sup>. PHES was used to diagnose HE. They found that a higher proportion of patients on the prescribed diet had reversal of HE (71.1% versus 22.9%, <i>p</i>=0.001) along with a decreased incidence of overt HE in the treatment group (10% versus 21.7%, <i>p</i>=0.4)<sup><a href="#ref-120">120</a></sup>.</p><p class="" id=d66598e1244>Alteration in the gut–brain axis in HE has led to investigations in determining the effectiveness of gut-selective antibiotics. Modulating the gut microbiota with the use of antibiotics such as rifaximin may improve cognitive performance in cirrhotics<sup><a href="#ref-121">121</a>–<a href="#ref-126">126</a></sup>. This hypothesis was tested in a study at the Hunter Holmes McGuire VA Medical Center<sup><a href="#ref-127">127</a></sup>. Patients with confirmed HE were prescribed rifaximin 550 mg oral twice a day over a period of eight weeks<sup><a href="#ref-127">127</a></sup>. Compared to the placebo group, the treatment group had cognitive improvement, decreased endotoxemia, and a modest decrease in bacteria of the small bowel<sup><a href="#ref-127">127</a></sup>.</p><p class="" id=d66598e1266>A retrospective, observational, cross-sectional study examined the efficacy of different rifaximin dosing (400 mg three times daily versus 550 mg twice daily)<sup><a href="#ref-128">128</a></sup>. There was no difference in readmission rates between the two treatment groups<sup><a href="#ref-128">128</a></sup>. The long-term cost effectiveness of lactulose monotherapy versus lactulose plus rifaximin was studied in France<sup><a href="#ref-129">129</a></sup>. Despite having no effect on hospital length of stay, combination therapy led to lower readmission rates at 180 days compared to lactulose alone<sup><a href="#ref-130">130</a></sup>. The authors concluded that rifaximin was a cost-effective and affordable treatment for patients suffering from at least two prior events of HE<sup><a href="#ref-129">129</a></sup>.</p></div><div class=section><a name=d66598e1290 class=n-a></a><h3 class=section-title>Hyperammonemia</h3><p class="" id=d66598e1295>As stated above, numerous studies have shown that ammonia is key in the pathogenesis of HE. Currently, the gold-standard treatment for the reduction of ammonia during HE is lactulose<sup><a href="#ref-131">131</a></sup>, although a number of other experimental drugs aimed at lowering ammonia have been trialed including ornithine phenylacetate (OP)<sup><a href="#ref-9">9</a>,<a href="#ref-132">132</a>–<a href="#ref-134">134</a></sup> and L-ornithine L-aspartate (LOLA)<sup><a href="#ref-135">135</a>–<a href="#ref-137">137</a></sup>. A major breakthrough came with an investigation of bacterial-DNA translocation effects on hyperammonemia and neurocognitive scores in patients with HE after the use of lactulose<sup><a href="#ref-131">131</a></sup>. The authors showed that neurocognitive scores improved with lactulose use and also led to reduced bacterial-DNA translocation<sup><a href="#ref-131">131</a></sup>.</p><p class="" id=d66598e1327>Evidence is mounting that the use of polyethylene glycol (PEG), with or without lactulose, is effective. A randomized controlled trial in 40 patients compared the use of lactulose versus combined lactulose and PEG in cirrhotic patients admitted with HE<sup><a href="#ref-138">138</a></sup>. There was a statistically significant decrease in length of hospital stay (in women)<sup><a href="#ref-138">138</a></sup>. Surprisingly, there was no effect on ammonia levels<sup><a href="#ref-138">138</a></sup>. Likewise, the HELP randomized trial found that, compared to lactulose, PEG led to more rapid HE resolution in the hospital and concluded that it was superior to standard lactulose therapy<sup><a href="#ref-139">139</a></sup>.</p><p class="" id=d66598e1346>Studies are investigating albumin transfusion as a possible treatment for HE<sup><a href="#ref-140">140</a></sup>. A prospective randomized controlled trial investigated lactulose alone versus lactulose plus albumin<sup><a href="#ref-140">140</a></sup>. Combination treatment of lactulose plus albumin led to a decrease in levels of ammonia, IL-6, IL-18, and TNF-α and other endotoxins<sup><a href="#ref-140">140</a></sup>.</p><p class="" id=d66598e1361>Studies are also investigating branched chain amino acid (BCAA) supplementation in advanced liver disease. The ratio of normal BCAAs to aromatic amino acids becomes reduced in HE<sup><a href="#ref-141">141</a></sup>. Randomized controlled studies show that BCAA supplementation does not prevent the development of HE but may slow down the progression of hepatic failure<sup><a href="#ref-141">141</a>,<a href="#ref-142">142</a></sup>. Despite BCAAs having no effect on mortality, 16 randomized controlled clinical trials have shown that BCAAs decrease the signs and symptoms of HE<sup><a href="#ref-143">143</a></sup>. Conflicting studies exist, with some stating BCAAs have no significant effect on HE<sup><a href="#ref-144">144</a></sup>.</p><p class="" id=d66598e1384>Recent studies have examined the use of corticosteroid administration in patients with acute liver injury and ALF<sup><a href="#ref-145">145</a></sup>. A prospective observational study of 469 patients from 2004 to 2015 showed that high-dose therapy decreased the risk of HE, but the time to initiate therapy has yet to be established<sup><a href="#ref-145">145</a></sup>.</p></div><div class=section><a name=d66598e1396 class=n-a></a><h3 class=section-title>Surgical treatment</h3><p class="" id=d66598e1401>As might be predicted, liver transplantation has been shown to improve the brain activity and cognitive function of patients with cirrhosis with or without HE<sup><a href="#ref-146">146</a></sup>. Zhang <i>et al</i>. studied the effect of liver transplant on resting-state brain activity by quantizing the ALFF before and one month after transplant. Cognitive function improved in both groups with and without encephalopathy, showing transplant as a viable treatment option for HE<sup><a href="#ref-146">146</a></sup>.</p><p class="" id=d66598e1415>In a case report, a 73-year-old male presented with new-onset HE and was found to have a congenital portosystemic shunt with a normal liver histology. Correction of the shunt led to full reversal of his symptoms<sup><a href="#ref-147">147</a></sup>. This highlights a surgically correctable cause of acute HE without underlying liver disease.</p><p class="" id=d66598e1422>An increase in shunt blood bypassing the liver owing to portal hypertension can result in HE. Surgical interventions to close these shunts have been studied as a possible treatment for HE<sup><a href="#ref-148">148</a></sup>. Percutaneous transhepatic obliteration (PTO) and percutaneous transhepatic sclerotherapy (PTS) are two methods used to close shunts in the setting of emergent variceal hemorrhage when other methods have failed<sup><a href="#ref-148">148</a></sup>. PTO is performed by placing metallic coils in the afferent veins to reduce blood flow, while PTS is performed by injecting a sclerosing agent<sup><a href="#ref-148">148</a></sup>. Both methods utilize an invasive transcutaneous intrahepatic puncture<sup><a href="#ref-148">148</a></sup>. A study of 37 patients with variceal hemorrhage and intractable HE underwent PTO/PTS<sup><a href="#ref-148">148</a></sup>. Blood ammonia levels greatly improved, dropping from 135 mg/dL to 65 mg/dL at six months, and there was also an improvement in HE<sup><a href="#ref-148">148</a></sup>.</p><p class="" id=d66598e1450>TIPS is a procedure that places a stent between the hepatic vein and portal vein to alleviate portal hypertension<sup><a href="#ref-149">149</a></sup>. However, allowing blood to bypass the liver can worsen HE<sup><a href="#ref-149">149</a>,<a href="#ref-150">150</a></sup>. The size of the stent in TIPS has been associated with HE<sup><a href="#ref-151">151</a>,<a href="#ref-152">152</a></sup>. One study showed that the use of a larger diameter stent improved ascites without a significant change in HE<sup><a href="#ref-151">151</a>,<a href="#ref-152">152</a></sup>. Additionally, the consumption of a low-protein diet after TIPS can reduce the incidence of HE<sup><a href="#ref-153">153</a></sup>. Interestingly, antegrade embolization of spontaneous splenorenal shunt has also been employed to decrease the incidence of post-TIPS HE and has decreased the rate of variceal bleeding<sup><a href="#ref-154">154</a></sup>.</p><p class="" id=d66598e1488>Balloon-occluded retrograde transvenous obliteration (BRTO) is an alternative or adjuvant to TIPS in the management of gastric varices<sup><a href="#ref-155">155</a></sup>. It works by abolishing gastrorenal or splenorenal shunts<sup><a href="#ref-155">155</a></sup>. A retrospective record-based study of patients who underwent BRTO for gastric variceal bleeding or refractory HE showed great improvement in grade of encephalopathy after BRTO<sup><a href="#ref-155">155</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d66598e1508>Conclusions</h2><p class="" id=d66598e1511>This review summarizes the advances made in basic and clinical research over the last three years that have furthered our understanding of the pathophysiology of HE and possible treatments. Recent developments in basic research have focused on the role of hyperammonemia, oxidative stress, neuroinflammation, neurotransmitter function, bile acids, and the blood–brain barrier. More research is needed in these areas to fully establish the mechanism behind these various components and the role they play in the pathophysiology of HE. The diagnosis of HE is being investigated and is expected to become more precise by optimizing and validating current scoring systems. It appears that at least some of these will be amenable to modern app technology. Research in non-invasive imaging is also active and promises to aid in the diagnosis of HE. Strides have been made in the treatment of HE by specifically targeting the gut microbiome and hyperammonemia.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d66598e1517>Abbreviations</h2><p class="" id=d66598e1520>AASLD, American Association for the Study of Liver Disease; ALF, acute liver failure; ALFF, amplitude of low-frequency fluctuation; AOM, azoxymethane; BCAA, branched chain amino acid; BRTO, balloon-occluded retrograde transvenous obliteration; CFF, critical flicker frequency test; EEG, electroencephalogram; EHPVO, extrahepatic portal vein obstruction; GMP, guanosine monophosphate; HE, hepatic encephalopathy; ICP, intracranial pressure; MELD, model for end stage liver disease; MHE, minimal hepatic encephalopathy; MRI, magnetic resonance imaging; PEG, polyethylene glycol; PHES, psychomotor hepatic encephalopathy score; PPI, proton pump inhibitor; PTO, percutaneous transhepatic obliteration; PTS, percutaneous transhepatic sclerotherapy; TIPS, transjugular intrahepatic portosystemic shunts.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d66598e1 class=n-a></a><h2 class=main-title id=d67077>Competing interests</h2><p class=metadata-entry><a name=d66598e120 class=n-a></a><p id=d66598e122> The authors declare that they have no competing interests.</p></p></div><div class=back-section><a name=d66598e1 class=n-a></a><h2 class=main-title id=d67079>Grant information</h2><p>This study was funded by an NIH R01 award (DK082435) and a VA Merit award (BX002638) from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service to Sharon DeMorrow.</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i></p></div><div class=back-section><a name=d66598e1527 class=n-a></a><h2 class=main-title id=d66598e1529>Acknowledgements</h2><p class="" id=d66598e1532>This work was completed with support from the Veterans Health Administration and with resources and the use of facilities at the Central Texas Veterans Health Care System, Temple, Texas. The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. </p></div><div class=back-section><a name=d66598e1536 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d67593>References</h2><div class="section ref-list"><a name=d66598e1536 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d66598e1543 class=n-a></a>Vilstrup H, Amodio P, Bajaj J, <i> et al.</i>: Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. <i>Hepatology.</i> 2014; <b>60</b>(2): 715–35. <a target=xrefwindow id=d66598e1554 href="http://www.ncbi.nlm.nih.gov/pubmed/25042402">PubMed Abstract </a> | <a target=xrefwindow id=d66598e1557 href="http://dx.doi.org/10.1002/hep.27210">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d66598e1566 class=n-a></a>Stepanova M, Mishra A, Venkatesan C, <i> et al.</i>: In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009. <i>Clin Gastroenterol Hepatol.</i> 2012; <b>10</b>(9): 1034–41.e1. <a target=xrefwindow id=d66598e1577 href="http://www.ncbi.nlm.nih.gov/pubmed/22642955">PubMed Abstract </a> | <a target=xrefwindow id=d66598e1580 href="http://dx.doi.org/10.1016/j.cgh.2012.05.016">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d66598e1589 class=n-a></a>Bernal W, Wendon J: Acute liver failure. <i>N Engl J Med.</i> 2013; <b>369</b>(26): 2525–34. <a target=xrefwindow id=d66598e1597 href="http://www.ncbi.nlm.nih.gov/pubmed/24369077">PubMed Abstract </a> | <a target=xrefwindow id=d66598e1600 href="http://dx.doi.org/10.1056/NEJMra1208937">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d66598e1609 class=n-a></a>Riggio O, Nardelli S, Moscucci F, <i> et al.</i>: Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. <i>Clin Liver Dis.</i> 2012; <b>16</b>(1): 133–46. <a target=xrefwindow id=d66598e1620 href="http://www.ncbi.nlm.nih.gov/pubmed/22321469">PubMed Abstract </a> | <a target=xrefwindow id=d66598e1623 href="http://dx.doi.org/10.1016/j.cld.2011.12.008">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d66598e1632 class=n-a></a>Wiegand J, Berg T: The etiology, diagnosis and prevention of liver cirrhosis: part 1 of a series on liver cirrhosis. <i>Dtsch Arztebl Int.</i> 2013; <b>110</b>(6): 85–91. <a target=xrefwindow id=d66598e1640 href="http://www.ncbi.nlm.nih.gov/pubmed/23451000">PubMed Abstract </a> | <a target=xrefwindow id=d66598e1643 href="http://dx.doi.org/10.3238/arztebl.2013.0085">Publisher Full Text </a> | <a target=xrefwindow id=d66598e1646 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3583179">Free Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d66598e1656 class=n-a></a>Basu PP, Shah NJ: Clinical and Neurologic Manifestation of Minimal Hepatic Encephalopathy and Overt Hepatic Encephalopathy. <i>Clin Liver Dis.</i> 2015; <b>19</b>(3): 461–72. <a target=xrefwindow id=d66598e1664 href="http://www.ncbi.nlm.nih.gov/pubmed/26195201">PubMed Abstract </a> | <a target=xrefwindow id=d66598e1667 href="http://dx.doi.org/10.1016/j.cld.2015.05.003">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d66598e1676 class=n-a></a>Flamm SL: Covert Hepatic Encephalopathy: Who Should Be Tested and Treated? <i>Clin Liver Dis.</i> 2015; <b>19</b>(3): 473–85. <a target=xrefwindow id=d66598e1684 href="http://www.ncbi.nlm.nih.gov/pubmed/26195202">PubMed Abstract </a> | <a target=xrefwindow id=d66598e1687 href="http://dx.doi.org/10.1016/j.cld.2015.04.007">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d66598e1696 class=n-a></a>Parekh PJ, Balart LA: Ammonia and Its Role in the Pathogenesis of Hepatic Encephalopathy. <i>Clin Liver Dis.</i> 2015; <b>19</b>(3): 529–37. <a target=xrefwindow id=d66598e1704 href="http://www.ncbi.nlm.nih.gov/pubmed/26195206">PubMed Abstract </a> | <a target=xrefwindow id=d66598e1707 href="http://dx.doi.org/10.1016/j.cld.2015.05.002">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d66598e1716 class=n-a></a>Romero-Gómez M, Montagnese S, Jalan R: Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure. <i>J Hepatol.</i> 2015; <b>62</b>(2): 437–47. <a target=xrefwindow id=d66598e1724 href="http://www.ncbi.nlm.nih.gov/pubmed/25218789">PubMed Abstract </a> | <a target=xrefwindow id=d66598e1727 href="http://dx.doi.org/10.1016/j.jhep.2014.09.005">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d66598e1736 class=n-a></a>Aldridge DR, Tranah EJ, Shawcross DL: Pathogenesis of hepatic encephalopathy: role of ammonia and systemic inflammation. <i>J Clin Exp Hepatol.</i> 2015; <b>5</b>(Suppl 1): S7–S20. <a target=xrefwindow id=d66598e1744 href="http://www.ncbi.nlm.nih.gov/pubmed/26041962">PubMed Abstract </a> | <a target=xrefwindow id=d66598e1747 href="http://dx.doi.org/10.1016/j.jceh.2014.06.004">Publisher Full Text </a> | <a target=xrefwindow id=d66598e1750 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4442852">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d66598e1759 class=n-a></a>Qvartskhava N, Lang PA, Görg B, <i> et al.</i>: Hyperammonemia in gene-targeted mice lacking functional hepatic glutamine synthetase. <i>Proc Natl Acad Sci U S A.</i> 2015; <b>112</b>(17): 5521–6. <a target=xrefwindow id=d66598e1770 href="http://www.ncbi.nlm.nih.gov/pubmed/25870278">PubMed Abstract </a> | <a target=xrefwindow id=d66598e1773 href="http://dx.doi.org/10.1073/pnas.1423968112">Publisher Full Text </a> | <a target=xrefwindow id=d66598e1777 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4418919">Free Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d66598e1787 class=n-a></a>Rackayova V, Braissant O, McLin VA, <i> et al.</i>: <sup>1</sup>H and <sup>31</sup>P magnetic resonance spectroscopy in a rat model of chronic hepatic encephalopathy: <i>in vivo</i> longitudinal measurements of brain energy metabolism. <i>Metab Brain Dis.</i> 2016; <b>31</b>(6): 1303–14. <a target=xrefwindow id=d66598e1808 href="http://www.ncbi.nlm.nih.gov/pubmed/26253240">PubMed Abstract </a> | <a target=xrefwindow id=d66598e1811 href="http://dx.doi.org/10.1007/s11011-015-9715-8">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d66598e1820 class=n-a></a>Haack N, Dublin P, Rose CR: Dysbalance of astrocyte calcium under hyperammonemic conditions. <i>PLoS One.</i> 2014; <b>9</b>(8): e105832. <a target=xrefwindow id=d66598e1828 href="http://www.ncbi.nlm.nih.gov/pubmed/25153709">PubMed Abstract </a> | <a target=xrefwindow id=d66598e1831 href="http://dx.doi.org/10.1371/journal.pone.0105832">Publisher Full Text </a> | <a target=xrefwindow id=d66598e1834 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4143319">Free Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d66598e1843 class=n-a></a>Liang C, Du T, Zhou J, <i> et al.</i>: Ammonium increases Ca<sup>2+</sup> signalling and up-regulates expression of TRPC1 gene in astrocytes in primary cultures and in the <i>in vivo</i> brain. <i>Neurochem Res.</i> 2014; <b>39</b>(11): 2127–35. <a target=xrefwindow id=d66598e1861 href="http://www.ncbi.nlm.nih.gov/pubmed/25113123">PubMed Abstract </a> | <a target=xrefwindow id=d66598e1864 href="http://dx.doi.org/10.1007/s11064-014-1406-z">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d66598e1873 class=n-a></a>Wang F, Du T, Liang C, <i> et al.</i>: Ammonium increases Ca<sup>2+</sup> signalling and upregulates expression of Ca<sub>v</sub>1.2 gene in astrocytes in primary cultures and in the <i>in vivo</i> brain. <i>Acta Physiol (Oxf).</i> 2015; <b>214</b>(2): 261–74. <a target=xrefwindow id=d66598e1894 href="http://www.ncbi.nlm.nih.gov/pubmed/25846713">PubMed Abstract </a> | <a target=xrefwindow id=d66598e1897 href="http://dx.doi.org/10.1111/apha.12500">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d66598e1906 class=n-a></a>Sobczyk K, Jördens MS, Karababa A, <i> et al.</i>: Ephrin/Ephrin receptor expression in ammonia-treated rat astrocytes and in human cerebral cortex in hepatic encephalopathy. <i>Neurochem Res.</i> 2015; <b>40</b>(2): 274–83. <a target=xrefwindow id=d66598e1917 href="http://www.ncbi.nlm.nih.gov/pubmed/25064044">PubMed Abstract </a> | <a target=xrefwindow id=d66598e1920 href="http://dx.doi.org/10.1007/s11064-014-1389-9">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d66598e1929 class=n-a></a>Karababa A, Görg B, Schliess F, <i> et al.</i>: <i>O</i>-GlcNAcylation as a novel ammonia-induced posttranslational protein modification in cultured rat astrocytes. <i>Metab Brain Dis.</i> 2014; <b>29</b>(4): 975–82. <a target=xrefwindow id=d66598e1943 href="http://www.ncbi.nlm.nih.gov/pubmed/24292976">PubMed Abstract </a> | <a target=xrefwindow id=d66598e1947 href="http://dx.doi.org/10.1007/s11011-013-9454-7">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d66598e1957 class=n-a></a>Görg B, Karababa A, Shafigullina A, <i> et al.</i>: Ammonia-induced senescence in cultured rat astrocytes and in human cerebral cortex in hepatic encephalopathy. <i>Glia.</i> 2015; <b>63</b>(1): 37–50. <a target=xrefwindow id=d66598e1968 href="http://www.ncbi.nlm.nih.gov/pubmed/25092802">PubMed Abstract </a> | <a target=xrefwindow id=d66598e1971 href="http://dx.doi.org/10.1002/glia.22731">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d66598e1980 class=n-a></a>Oenarto J, Karababa A, Castoldi M, <i> et al.</i>: Ammonia-induced miRNA expression changes in cultured rat astrocytes. <i>Sci Rep.</i> 2016; <b>6</b>: 18493. <a target=xrefwindow id=d66598e1991 href="http://www.ncbi.nlm.nih.gov/pubmed/26755400">PubMed Abstract </a> | <a target=xrefwindow id=d66598e1994 href="http://dx.doi.org/10.1038/srep18493">Publisher Full Text </a> | <a target=xrefwindow id=d66598e1998 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4709596">Free Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d66598e2007 class=n-a></a>Jayakumar AR, Tong XY, Curtis KM, <i> et al.</i>: Decreased astrocytic thrombospondin-1 secretion after chronic ammonia treatment reduces the level of synaptic proteins: <i>in vitro</i> and <i>in vivo</i> studies. <i>J Neurochem.</i> 2014; <b>131</b>(3): 333–47. <a target=xrefwindow id=d66598e2025 href="http://www.ncbi.nlm.nih.gov/pubmed/25040426">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2028 href="http://dx.doi.org/10.1111/jnc.12810">Publisher Full Text </a> | <a target=xrefwindow id=d66598e2031 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4364553">Free Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d66598e2040 class=n-a></a>Jayakumar AR, Tong XY, Curtis KM, <i> et al.</i>: Increased toll-like receptor 4 in cerebral endothelial cells contributes to the astrocyte swelling and brain edema in acute hepatic encephalopathy. <i>J Neurochem.</i> 2014; <b>128</b>(6): 890–903. <a target=xrefwindow id=d66598e2051 href="http://www.ncbi.nlm.nih.gov/pubmed/24261962">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2054 href="http://dx.doi.org/10.1111/jnc.12516">Publisher Full Text </a> | <a target=xrefwindow id=d66598e2058 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3951576">Free Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d66598e2067 class=n-a></a>Bobermin LD, Arús BA, Leite MC, <i> et al.</i>: Gap Junction Intercellular Communication Mediates Ammonia-Induced Neurotoxicity. <i>Neurotox Res.</i> 2016; <b>29</b>(2): 314–24. <a target=xrefwindow id=d66598e2078 href="http://www.ncbi.nlm.nih.gov/pubmed/26646155">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2081 href="http://dx.doi.org/10.1007/s12640-015-9581-5">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d66598e2090 class=n-a></a>Lemberg A, Fernández MA: Hepatic encephalopathy, ammonia, glutamate, glutamine and oxidative stress. <i>Ann Hepatol.</i> 2009; <b>8</b>(2): 95–102. <a target=xrefwindow id=d66598e2098 href="http://www.ncbi.nlm.nih.gov/pubmed/19502650">PubMed Abstract </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d66598e2108 class=n-a></a>Milewski K, Hilgier W, Albrecht J, <i> et al.</i>: The dimethylarginine (ADMA)/nitric oxide pathway in the brain and periphery of rats with thioacetamide-induced acute liver failure: Modulation by histidine. <i>Neurochem Int.</i> 2015; <b>88</b>: 26–31. <a target=xrefwindow id=d66598e2119 href="http://www.ncbi.nlm.nih.gov/pubmed/25523831">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2122 href="http://dx.doi.org/10.1016/j.neuint.2014.12.004">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d66598e2131 class=n-a></a>Ruszkiewicz J, Albrecht J: Changes of the thioredoxin system, glutathione peroxidase activity and total antioxidant capacity in rat brain cortex during acute liver failure: modulation by L-histidine. <i>Neurochem Res.</i> 2015; <b>40</b>(2): 293–300. <a target=xrefwindow id=d66598e2139 href="http://www.ncbi.nlm.nih.gov/pubmed/25161077">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2142 href="http://dx.doi.org/10.1007/s11064-014-1417-9">Publisher Full Text </a> | <a target=xrefwindow id=d66598e2145 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4326661">Free Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d66598e2154 class=n-a></a>Bobermin LD, Wartchow KM, Flores MP, <i> et al.</i>: Ammonia-induced oxidative damage in neurons is prevented by resveratrol and lipoic acid with participation of heme oxygenase 1. <i>Neurotoxicology.</i> 2015; <b>49</b>: 28–35. <a target=xrefwindow id=d66598e2165 href="http://www.ncbi.nlm.nih.gov/pubmed/26003724">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2168 href="http://dx.doi.org/10.1016/j.neuro.2015.05.005">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d66598e2177 class=n-a></a>Chang CC, Lee WS, Chuang CL, <i> et al.</i>: Effects of raloxifene on portal hypertension and hepatic encephalopathy in cirrhotic rats. <i>Eur J Pharmacol.</i> 2017; <b>802</b>: 36–43. <a target=xrefwindow id=d66598e2188 href="http://www.ncbi.nlm.nih.gov/pubmed/28238769">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2191 href="http://dx.doi.org/10.1016/j.ejphar.2017.02.039">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d66598e2200 class=n-a></a>Ghiassy B, Rahimi N, Javadi-Paydar M, <i> et al.</i>: Nitric oxide mediates effects of acute, not chronic, naltrexone on LPS-induced hepatic encephalopathy in cirrhotic rats. <i>Can J Physiol Pharmacol.</i> 2017; <b>95</b>(1): 16–22. <a target=xrefwindow id=d66598e2211 href="http://www.ncbi.nlm.nih.gov/pubmed/28044452">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2214 href="http://dx.doi.org/10.1139/cjpp-2016-0188">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d66598e2223 class=n-a></a>Jamshidzadeh A, Heidari R, Abasvali M, <i> et al.</i>: Taurine treatment preserves brain and liver mitochondrial function in a rat model of fulminant hepatic failure and hyperammonemia. <i>Biomed Pharmacother.</i> 2017; <b>86</b>: 514–20. <a target=xrefwindow id=d66598e2234 href="http://www.ncbi.nlm.nih.gov/pubmed/28024286">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2237 href="http://dx.doi.org/10.1016/j.biopha.2016.11.095">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d66598e2247 class=n-a></a>Milewski K, Hilgier W, Fręśko I, <i> et al.</i>: Carnosine Reduces Oxidative Stress and Reverses Attenuation of Righting and Postural Reflexes in Rats with Thioacetamide-Induced Liver Failure. <i>Neurochem Res.</i> 2016; <b>41</b>(1–2): 376–84. <a target=xrefwindow id=d66598e2258 href="http://www.ncbi.nlm.nih.gov/pubmed/26801175">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2261 href="http://dx.doi.org/10.1007/s11064-015-1821-9">Publisher Full Text </a> | <a target=xrefwindow id=d66598e2265 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4773466">Free Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d66598e2274 class=n-a></a>Wu YB, Zhang L, Li WT, <i> et al.</i>: Artesunate restores spatial learning of rats with hepatic encephalopathy by inhibiting ammonia-induced oxidative damage in neurons and dysfunction of glutamate signaling in astroglial cells. <i>Biomed Pharmacother.</i> 2016; <b>84</b>: 972–8. <a target=xrefwindow id=d66598e2285 href="http://www.ncbi.nlm.nih.gov/pubmed/27764760">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2288 href="http://dx.doi.org/10.1016/j.biopha.2016.09.104">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d66598e2297 class=n-a></a>Mladenović D, Petronijević N, Stojković T, <i> et al.</i>: Finasteride Has Regionally Different Effects on Brain Oxidative Stress and Acetylcholinesterase Activity in Acute Thioacetamide-Induced Hepatic Encephalopathy in Rats. <i>PLoS One.</i> 2015; <b>10</b>(8): e0134434. <a target=xrefwindow id=d66598e2308 href="http://www.ncbi.nlm.nih.gov/pubmed/26241899">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2311 href="http://dx.doi.org/10.1371/journal.pone.0134434">Publisher Full Text </a> | <a target=xrefwindow id=d66598e2315 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4524603">Free Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729074367"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e2324 class=n-a></a>Bosoi CR, Tremblay M, Rose CF: Induction of systemic oxidative stress leads to brain oedema in portacaval shunted rats. <i>Liver Int.</i> 2014; <b>34</b>(9): 1322–9. <a target=xrefwindow id=d66598e2332 href="http://www.ncbi.nlm.nih.gov/pubmed/25354203">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2335 href="http://dx.doi.org/10.1111/liv.12414">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729074367">F1000 Recommendation</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d66598e2348 class=n-a></a>Rama Rao KV, Norenberg MD: Brain energy metabolism and mitochondrial dysfunction in acute and chronic hepatic encephalopathy. <i>Neurochem Int.</i> 2012; <b>60</b>(7): 697–706. <a target=xrefwindow id=d66598e2356 href="http://www.ncbi.nlm.nih.gov/pubmed/21989389">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2359 href="http://dx.doi.org/10.1016/j.neuint.2011.09.007">Publisher Full Text </a> | <a target=xrefwindow id=d66598e2362 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4714837">Free Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d66598e2371 class=n-a></a>Walsh TS, McLellan S, Mackenzie SJ, <i> et al.</i>: Hyperlactatemia and pulmonary lactate production in patients with fulminant hepatic failure. <i>Chest.</i> 1999; <b>116</b>(2): 471–6. <a target=xrefwindow id=d66598e2382 href="http://www.ncbi.nlm.nih.gov/pubmed/10453878">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2385 href="http://dx.doi.org/10.1378/chest.116.2.471">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d66598e2395 class=n-a></a>Rose C, Ytrebø LM, Davies NA, <i> et al.</i>: Association of reduced extracellular brain ammonia, lactate, and intracranial pressure in pigs with acute liver failure. <i>Hepatology.</i> 2007; <b>46</b>(6): 1883–92. <a target=xrefwindow id=d66598e2406 href="http://www.ncbi.nlm.nih.gov/pubmed/17705298">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2409 href="http://dx.doi.org/10.1002/hep.21877">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d66598e2418 class=n-a></a>Zwingmann C, Chatauret N, Leibfritz D, <i> et al.</i>: Selective increase of brain lactate synthesis in experimental acute liver failure: results of a [H-C] nuclear magnetic resonance study. <i>Hepatology.</i> 2003; <b>37</b>(2): 420–8. <a target=xrefwindow id=d66598e2429 href="http://www.ncbi.nlm.nih.gov/pubmed/12540793">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2432 href="http://dx.doi.org/10.1053/jhep.2003.50052">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d66598e2441 class=n-a></a>Fitzpatrick SM, Hetherington HP, Behar KL, <i> et al.</i>: Effects of acute hyperammonemia on cerebral amino acid metabolism and pH<sub>i</sub> <i>in vivo</i>, measured by <sup>1</sup>H and <sup>31</sup>P nuclear magnetic resonance. <i>J Neurochem.</i> 1989; <b>52</b>(3): 741–9. <a target=xrefwindow id=d66598e2465 href="http://www.ncbi.nlm.nih.gov/pubmed/2563756">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2468 href="http://dx.doi.org/10.1111/j.1471-4159.1989.tb02517.x">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d66598e2477 class=n-a></a>Dabos KJ, Parkinson JA, Sadler IH, <i> et al.</i>: <sup>1</sup>H nuclear magnetic resonance spectroscopy-based metabonomic study in patients with cirrhosis and hepatic encephalopathy. <i>World J Hepatol.</i> 2015; <b>7</b>(12): 1701–7. <a target=xrefwindow id=d66598e2491 href="http://www.ncbi.nlm.nih.gov/pubmed/26140090">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2495 href="http://dx.doi.org/10.4254/wjh.v7.i12.1701">Publisher Full Text </a> | <a target=xrefwindow id=d66598e2498 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4483552">Free Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d66598e2507 class=n-a></a>Bosoi CR, Zwingmann C, Marin H, <i> et al.</i>: Increased brain lactate is central to the development of brain edema in rats with chronic liver disease. <i>J Hepatol.</i> 2014; <b>60</b>(3): 554–60. <a target=xrefwindow id=d66598e2518 href="http://www.ncbi.nlm.nih.gov/pubmed/24512824">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2521 href="http://dx.doi.org/10.1016/j.jhep.2013.10.011">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727188191"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e2530 class=n-a></a>Hadjihambi A, de Chiara F, Hosford PS, <i> et al.</i>: Ammonia mediates cortical hemichannel dysfunction in rodent models of chronic liver disease. <i>Hepatology.</i> 2017; <b>65</b>(4): 1306–18. <a target=xrefwindow id=d66598e2541 href="http://www.ncbi.nlm.nih.gov/pubmed/28066916">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2544 href="http://dx.doi.org/10.1002/hep.29031">Publisher Full Text </a> | <a target=xrefwindow id=d66598e2548 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5396295">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727188191">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d66598e2562 class=n-a></a>Magistretti PJ: Neuron-glia metabolic coupling and plasticity. <i>J Exp Biol.</i> 2006; <b>209</b>(Pt 12): 2304–11. <a target=xrefwindow id=d66598e2570 href="http://www.ncbi.nlm.nih.gov/pubmed/16731806">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2573 href="http://dx.doi.org/10.1242/jeb.02208">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d66598e2582 class=n-a></a>Zemtsova I, Görg B, Keitel V, <i> et al.</i>: Microglia activation in hepatic encephalopathy in rats and humans. <i>Hepatology.</i> 2011; <b>54</b>(1): 204–15. <a target=xrefwindow id=d66598e2593 href="http://www.ncbi.nlm.nih.gov/pubmed/21452284">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2596 href="http://dx.doi.org/10.1002/hep.24326">Publisher Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d66598e2605 class=n-a></a>Görg B, Bidmon HJ, Häussinger D: Gene expression profiling in the cerebral cortex of patients with cirrhosis with and without hepatic encephalopathy. <i>Hepatology.</i> 2013; <b>57</b>(6): 2436–47. <a target=xrefwindow id=d66598e2613 href="http://www.ncbi.nlm.nih.gov/pubmed/23325665">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2616 href="http://dx.doi.org/10.1002/hep.26265">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d66598e2625 class=n-a></a>McMillin M, Grant S, Frampton G, <i> et al.</i>: Fractalkine suppression during hepatic encephalopathy promotes neuroinflammation in mice. <i>J Neuroinflammation.</i> 2016; <b>13</b>(1): 198. <a target=xrefwindow id=d66598e2636 href="http://www.ncbi.nlm.nih.gov/pubmed/27561705">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2639 href="http://dx.doi.org/10.1186/s12974-016-0674-8">Publisher Full Text </a> | <a target=xrefwindow id=d66598e2643 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5000400">Free Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d66598e2652 class=n-a></a>McMillin M, Frampton G, Thompson M, <i> et al.</i>: Neuronal CCL2 is upregulated during hepatic encephalopathy and contributes to microglia activation and neurological decline. <i>J Neuroinflammation.</i> 2014; <b>11</b>: 121. <a target=xrefwindow id=d66598e2663 href="http://www.ncbi.nlm.nih.gov/pubmed/25012628">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2666 href="http://dx.doi.org/10.1186/1742-2094-11-121">Publisher Full Text </a> | <a target=xrefwindow id=d66598e2670 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4128607">Free Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726152377"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e2679 class=n-a></a>Hernández-Rabaza V, Cabrera-Pastor A, Taoro-González L, <i> et al.</i>: Hyperammonemia induces glial activation, neuroinflammation and alters neurotransmitter receptors in hippocampus, impairing spatial learning: reversal by sulforaphane. <i>J Neuroinflammation.</i> 2016; <b>13</b>: 41. <a target=xrefwindow id=d66598e2690 href="http://www.ncbi.nlm.nih.gov/pubmed/26883214">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2693 href="http://dx.doi.org/10.1186/s12974-016-0505-y">Publisher Full Text </a> | <a target=xrefwindow id=d66598e2697 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4754839">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726152377">F1000 Recommendation</a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d66598e2711 class=n-a></a>Agusti A, Hernández-Rabaza V, Balzano T, <i> et al.</i>: Sildenafil reduces neuroinflammation in cerebellum, restores GABAergic tone, and improves motor in-coordination in rats with hepatic encephalopathy. <i>CNS Neurosci Ther.</i> 2017; <b>23</b>(5): 386–94. <a target=xrefwindow id=d66598e2722 href="http://www.ncbi.nlm.nih.gov/pubmed/28296282">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2725 href="http://dx.doi.org/10.1111/cns.12688">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d66598e2734 class=n-a></a>Hernandez-Rabaza V, Agusti A, Cabrera-Pastor A, <i> et al.</i>: Sildenafil reduces neuroinflammation and restores spatial learning in rats with hepatic encephalopathy: underlying mechanisms. <i>J Neuroinflammation.</i> 2015; <b>12</b>: 195. <a target=xrefwindow id=d66598e2745 href="http://www.ncbi.nlm.nih.gov/pubmed/26511444">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2748 href="http://dx.doi.org/10.1186/s12974-015-0420-7">Publisher Full Text </a> | <a target=xrefwindow id=d66598e2752 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4625867">Free Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d66598e2761 class=n-a></a>Hernandez-Rabaza V, Cabrera-Pastor A, Taoro-Gonzalez L, <i> et al.</i>: Neuroinflammation increases GABAergic tone and impairs cognitive and motor function in hyperammonemia by increasing GAT-3 membrane expression. Reversal by sulforaphane by promoting M2 polarization of microglia. <i>J Neuroinflammation.</i> 2016; <b>13</b>(1): 83. <a target=xrefwindow id=d66598e2772 href="http://www.ncbi.nlm.nih.gov/pubmed/27090509">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2775 href="http://dx.doi.org/10.1186/s12974-016-0549-z">Publisher Full Text </a> | <a target=xrefwindow id=d66598e2779 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4835883">Free Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d66598e2788 class=n-a></a>Agusti A, Dziedzic JL, Hernandez-Rabaza V, <i> et al.</i>: Rats with minimal hepatic encephalopathy due to portacaval shunt show differential increase of translocator protein (18 kDa) binding in different brain areas, which is not affected by chronic MAP-kinase p38 inhibition. <i>Metab Brain Dis.</i> 2014; <b>29</b>(4): 955–63. <a target=xrefwindow id=d66598e2799 href="http://www.ncbi.nlm.nih.gov/pubmed/24307181">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2802 href="http://dx.doi.org/10.1007/s11011-013-9461-8">Publisher Full Text </a> | <a target=xrefwindow id=d66598e2806 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4087148">Free Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d66598e2815 class=n-a></a>McMillin M, Galindo C, Pae HY, <i> et al.</i>: Gli1 activation and protection against hepatic encephalopathy is suppressed by circulating transforming growth factor β1 in mice. <i>J Hepatol.</i> 2014; <b>61</b>(6): 1260–6. <a target=xrefwindow id=d66598e2826 href="http://www.ncbi.nlm.nih.gov/pubmed/25046848">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2829 href="http://dx.doi.org/10.1016/j.jhep.2014.07.015">Publisher Full Text </a> | <a target=xrefwindow id=d66598e2833 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4253574">Free Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d66598e2842 class=n-a></a>Llansola M, Montoliu C, Agusti A, <i> et al.</i>: Interplay between glutamatergic and GABAergic neurotransmission alterations in cognitive and motor impairment in minimal hepatic encephalopathy. <i>Neurochem Int.</i> 2015; <b>88</b>: 15–9. <a target=xrefwindow id=d66598e2853 href="http://www.ncbi.nlm.nih.gov/pubmed/25447766">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2856 href="http://dx.doi.org/10.1016/j.neuint.2014.10.011">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d66598e2866 class=n-a></a>Obara-Michlewska M, Ruszkiewicz J, Zielińska M, <i> et al.</i>: Astroglial NMDA receptors inhibit expression of K<sub>ir</sub>4.1 channels in glutamate-overexposed astrocytes <i>in vitro</i> and in the brain of rats with acute liver failure. <i>Neurochem Int.</i> 2015; <b>88</b>: 20–5. <a target=xrefwindow id=d66598e2884 href="http://www.ncbi.nlm.nih.gov/pubmed/25451797">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2887 href="http://dx.doi.org/10.1016/j.neuint.2014.10.006">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d66598e2896 class=n-a></a>Tong X, Ao Y, Faas GC, <i> et al.</i>: Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice. <i>Nat Neurosci.</i> 2014; <b>17</b>(5): 694–703. <a target=xrefwindow id=d66598e2907 href="http://www.ncbi.nlm.nih.gov/pubmed/24686787">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2910 href="http://dx.doi.org/10.1038/nn.3691">Publisher Full Text </a> | <a target=xrefwindow id=d66598e2914 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4064471">Free Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d66598e2923 class=n-a></a>Cauli O, González-Usano A, Cabrera-Pastor A, <i> et al.</i>: Blocking NMDA receptors delays death in rats with acute liver failure by dual protective mechanisms in kidney and brain. <i>Neuromolecular Med.</i> 2014; <b>16</b>(2): 360–75. <a target=xrefwindow id=d66598e2934 href="http://www.ncbi.nlm.nih.gov/pubmed/24338618">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2937 href="http://dx.doi.org/10.1007/s12017-013-8283-5">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d66598e2946 class=n-a></a>Gonzalez-Usano A, Cauli O, Agusti A, <i> et al.</i>: Pregnenolone sulfate restores the glutamate-nitric-oxide-cGMP pathway and extracellular GABA in cerebellum and learning and motor coordination in hyperammonemic rats. <i>ACS Chem Neurosci.</i> 2014; <b>5</b>(2): 100–5. <a target=xrefwindow id=d66598e2957 href="http://www.ncbi.nlm.nih.gov/pubmed/24256194">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2960 href="http://dx.doi.org/10.1021/cn400168y">Publisher Full Text </a> | <a target=xrefwindow id=d66598e2964 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3930995">Free Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d66598e2973 class=n-a></a>Ding S, Huang W, Ye Y, <i> et al.</i>: Elevated intracranial dopamine impairs the glutamate‑nitric oxide‑cyclic guanosine monophosphate pathway in cortical astrocytes in rats with minimal hepatic encephalopathy. <i>Mol Med Rep.</i> 2014; <b>10</b>(3): 1215–24. <a target=xrefwindow id=d66598e2984 href="http://www.ncbi.nlm.nih.gov/pubmed/25059564">PubMed Abstract </a> | <a target=xrefwindow id=d66598e2987 href="http://dx.doi.org/10.3892/mmr.2014.2386">Publisher Full Text </a> | <a target=xrefwindow id=d66598e2991 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4121426">Free Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d66598e3000 class=n-a></a>Palomero-Gallagher N, Zilles K: Neurotransmitter receptor alterations in hepatic encephalopathy: a review. <i>Arch Biochem Biophys.</i> 2013; <b>536</b>(2): 109–21. <a target=xrefwindow id=d66598e3008 href="http://www.ncbi.nlm.nih.gov/pubmed/23466244">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3011 href="http://dx.doi.org/10.1016/j.abb.2013.02.010">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d66598e3021 class=n-a></a>Butterworth RF: Neurosteroids in hepatic encephalopathy: Novel insights and new therapeutic opportunities. <i>J Steroid Biochem Mol Biol.</i> 2016; <b>160</b>: 94–7. <a target=xrefwindow id=d66598e3029 href="http://www.ncbi.nlm.nih.gov/pubmed/26589093">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3032 href="http://dx.doi.org/10.1016/j.jsbmb.2015.11.006">Publisher Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d66598e3041 class=n-a></a>Tsutsui K, Haraguchi S: Breakthrough in neuroendocrinology by discovering novel neuropeptides and neurosteroids: 2. Discovery of neurosteroids and pineal neurosteroids. <i>Gen Comp Endocrinol.</i> 2014; <b>205</b>: 11–22. <a target=xrefwindow id=d66598e3049 href="http://www.ncbi.nlm.nih.gov/pubmed/24704561">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3052 href="http://dx.doi.org/10.1016/j.ygcen.2014.03.008">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d66598e3061 class=n-a></a>Mladenović D, Hrnčić D, Petronijević N, <i> et al.</i>: Finasteride improves motor, EEG, and cellular changes in rat brain in thioacetamide-induced hepatic encephalopathy. <i>Am J Physiol Gastrointest Liver Physiol.</i> 2014; <b>307</b>(9): G931–40. <a target=xrefwindow id=d66598e3072 href="http://www.ncbi.nlm.nih.gov/pubmed/25104500">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3075 href="http://dx.doi.org/10.1152/ajpgi.00463.2013">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d66598e3084 class=n-a></a>Johansson M, Agusti A, Llansola M, <i> et al.</i>: GR3027 antagonizes GABA<sub>A</sub> receptor-potentiating neurosteroids and restores spatial learning and motor coordination in rats with chronic hyperammonemia and hepatic encephalopathy. <i>Am J Physiol Gastrointest Liver Physiol.</i> 2015; <b>309</b>(5): G400–9. <a target=xrefwindow id=d66598e3098 href="http://www.ncbi.nlm.nih.gov/pubmed/26138462">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3102 href="http://dx.doi.org/10.1152/ajpgi.00073.2015">Publisher Full Text </a> | <a target=xrefwindow id=d66598e3105 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4556948">Free Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d66598e3114 class=n-a></a>Ding S, Liu L, Jing H, <i> et al.</i>: Dopamine from cirrhotic liver contributes to the impaired learning and memory ability of hippocampus in minimal hepatic encephalopathy. <i>Hepatol Int.</i> 2013; <b>7</b>(3): 923–36. <a target=xrefwindow id=d66598e3125 href="http://www.ncbi.nlm.nih.gov/pubmed/26201931">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3128 href="http://dx.doi.org/10.1007/s12072-013-9431-6">Publisher Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d66598e3137 class=n-a></a>Ding S, Hu J, Yang J, <i> et al.</i>: The inactivation of JAK2/STAT3 signaling and desensitization of M1 mAChR in minimal hepatic encephalopathy (MHE) and the protection of naringin against MHE. <i>Cell Physiol Biochem.</i> 2014; <b>34</b>(6): 1933–50. <a target=xrefwindow id=d66598e3148 href="http://www.ncbi.nlm.nih.gov/pubmed/25500624">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3151 href="http://dx.doi.org/10.1159/000366391">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d66598e3161 class=n-a></a>Ding S, Wang W, Wang X, <i> et al.</i>: Dopamine Burden Triggers Neurodegeneration via Production and Release of TNF-α from Astrocytes in Minimal Hepatic Encephalopathy. <i>Mol Neurobiol.</i> 2016; <b>53</b>(8): 5324–43. <a target=xrefwindow id=d66598e3172 href="http://www.ncbi.nlm.nih.gov/pubmed/26433377">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3175 href="http://dx.doi.org/10.1007/s12035-015-9445-2">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d66598e3184 class=n-a></a>Dhanda S, Sandhir R: Role of dopaminergic and serotonergic neurotransmitters in behavioral alterations observed in rodent model of hepatic encephalopathy. <i>Behav Brain Res.</i> 2015; <b>286</b>: 222–35. <a target=xrefwindow id=d66598e3192 href="http://www.ncbi.nlm.nih.gov/pubmed/25639545">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3195 href="http://dx.doi.org/10.1016/j.bbr.2015.01.042">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d66598e3204 class=n-a></a>Bron B, Waldram R, Silk DB, <i> et al.</i>: Serum, cerebrospinal fluid, and brain levels of bile acids in patients with fulminant hepatic failure. <i>Gut.</i> 1977; <b>18</b>(9): 692–6. <a target=xrefwindow id=d66598e3215 href="http://www.ncbi.nlm.nih.gov/pubmed/604189">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3218 href="http://dx.doi.org/10.1136/gut.18.9.692">Publisher Full Text </a> | <a target=xrefwindow id=d66598e3222 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1411636">Free Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d66598e3231 class=n-a></a>McMillin M, Frampton G, Quinn M, <i> et al.</i>: Bile Acid Signaling Is Involved in the Neurological Decline in a Murine Model of Acute Liver Failure. <i>Am J Pathol.</i> 2016; <b>186</b>(2): 312–23. <a target=xrefwindow id=d66598e3242 href="http://www.ncbi.nlm.nih.gov/pubmed/26683664">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3245 href="http://dx.doi.org/10.1016/j.ajpath.2015.10.005">Publisher Full Text </a> | <a target=xrefwindow id=d66598e3249 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4729266">Free Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d66598e3258 class=n-a></a>Quinn M, McMillin M, Galindo C, <i> et al.</i>: Bile acids permeabilize the blood brain barrier after bile duct ligation in rats via Rac1-dependent mechanisms. <i>Dig Liver Dis.</i> 2014; <b>46</b>(6): 527–34. <a target=xrefwindow id=d66598e3269 href="http://www.ncbi.nlm.nih.gov/pubmed/24629820">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3272 href="http://dx.doi.org/10.1016/j.dld.2014.01.159">Publisher Full Text </a> | <a target=xrefwindow id=d66598e3276 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4065628">Free Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d66598e3285 class=n-a></a>Tripodi V, Contin M, Fernández MA, <i> et al.</i>: Bile acids content in brain of common duct ligated rats. <i>Ann Hepatol.</i> 2012; <b>11</b>(6): 930–4. <a target=xrefwindow id=d66598e3296 href="http://www.ncbi.nlm.nih.gov/pubmed/23111582">PubMed Abstract </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d66598e3306 class=n-a></a>Weiss N, Barbier Saint Hilaire P, Colsch B, <i> et al.</i>: Cerebrospinal fluid metabolomics highlights dysregulation of energy metabolism in overt hepatic encephalopathy. <i>J Hepatol.</i> 2016; <b>65</b>(6): 1120–30. <a target=xrefwindow id=d66598e3317 href="http://www.ncbi.nlm.nih.gov/pubmed/27520878">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3320 href="http://dx.doi.org/10.1016/j.jhep.2016.07.046">Publisher Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d66598e3329 class=n-a></a>Wright G, Swain M, Annane D, <i> et al.</i>: Neuroinflammation in liver disease: sessional talks from ISHEN. <i>Metab Brain Dis.</i> 2016; <b>31</b>(6): 1339–54. <a target=xrefwindow id=d66598e3340 href="http://www.ncbi.nlm.nih.gov/pubmed/27726053">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3343 href="http://dx.doi.org/10.1007/s11011-016-9918-7">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d66598e3352 class=n-a></a>Keitel V, Görg B, Bidmon HJ, <i> et al.</i>: The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain. <i>Glia.</i> 2010; <b>58</b>(15): 1794–805. <a target=xrefwindow id=d66598e3363 href="http://www.ncbi.nlm.nih.gov/pubmed/20665558">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3366 href="http://dx.doi.org/10.1002/glia.21049">Publisher Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d66598e3375 class=n-a></a>McMillin M, Frampton G, Tobin R, <i> et al.</i>: TGR5 signaling reduces neuroinflammation during hepatic encephalopathy. <i>J Neurochem.</i> 2015; <b>135</b>(3): 565–76. <a target=xrefwindow id=d66598e3386 href="http://www.ncbi.nlm.nih.gov/pubmed/26179031">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3389 href="http://dx.doi.org/10.1111/jnc.13243">Publisher Full Text </a> | <a target=xrefwindow id=d66598e3393 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5031412">Free Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d66598e3402 class=n-a></a>Dhanda S, Sandhir R: Blood-Brain Barrier Permeability Is Exacerbated in Experimental Model of Hepatic Encephalopathy via MMP-9 Activation and Downregulation of Tight Junction Proteins. <i>Mol Neurobiol.</i> 2017. <a target=xrefwindow id=d66598e3407 href="http://www.ncbi.nlm.nih.gov/pubmed/28523565">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3410 href="http://dx.doi.org/10.1007/s12035-017-0521-7">Publisher Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d66598e3419 class=n-a></a>Weiss N, Rosselli M, Mouri S, <i> et al.</i>: Modification in CSF specific gravity in acutely decompensated cirrhosis and acute on chronic liver failure independent of encephalopathy, evidences for an early blood-CSF barrier dysfunction in cirrhosis. <i>Metab Brain Dis.</i> 2017; <b>32</b>(2): 369–76. <a target=xrefwindow id=d66598e3430 href="http://www.ncbi.nlm.nih.gov/pubmed/27730496">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3433 href="http://dx.doi.org/10.1007/s11011-016-9916-9">Publisher Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d66598e3443 class=n-a></a>McMillin MA, Frampton GA, Seiwell AP, <i> et al.</i>: TGF<i>β</i>1 exacerbates blood-brain barrier permeability in a mouse model of hepatic encephalopathy via upregulation of MMP9 and downregulation of claudin-5. <i>Lab Invest.</i> 2015; <b>95</b>(8): 903–13. <a target=xrefwindow id=d66598e3457 href="http://www.ncbi.nlm.nih.gov/pubmed/26006017">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3461 href="http://dx.doi.org/10.1038/labinvest.2015.70">Publisher Full Text </a> | <a target=xrefwindow id=d66598e3464 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5040071">Free Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d66598e3473 class=n-a></a>Shimojima N, Eckman CB, McKinney M, <i> et al.</i>: Altered expression of zonula occludens-2 precedes increased blood-brain barrier permeability in a murine model of fulminant hepatic failure. <i>J Invest Surg.</i> 2008; <b>21</b>(3): 101–8. <a target=xrefwindow id=d66598e3484 href="http://www.ncbi.nlm.nih.gov/pubmed/18569429">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3487 href="http://dx.doi.org/10.1080/08941930802043565">Publisher Full Text </a> | <a target=xrefwindow id=d66598e3491 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2667930">Free Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d66598e3500 class=n-a></a>Chastre A, Bélanger M, Nguyen BN, <i> et al.</i>: Lipopolysaccharide precipitates hepatic encephalopathy and increases blood-brain barrier permeability in mice with acute liver failure. <i>Liver Int.</i> 2014; <b>34</b>(3): 353–61. <a target=xrefwindow id=d66598e3511 href="http://www.ncbi.nlm.nih.gov/pubmed/23910048">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3514 href="http://dx.doi.org/10.1111/liv.12252">Publisher Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d66598e3523 class=n-a></a>De Rui M, Montagnese S, Amodio P: Recent developments in the diagnosis and treatment of covert/minimal hepatic encephalopathy. <i>Expert Rev Gastroenterol Hepatol.</i> 2016; <b>10</b>(4): 443–50. <a target=xrefwindow id=d66598e3531 href="http://www.ncbi.nlm.nih.gov/pubmed/26758861">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3534 href="http://dx.doi.org/10.1586/17474124.2016.1141675">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d66598e3543 class=n-a></a>Sharma P: Critical flicker frequency: A stethoscope for minimal hepatic encephalopathy evaluation. <i>Turk J Gastroenterol.</i> 2017; <b>28</b>(3): 155–6. <a target=xrefwindow id=d66598e3551 href="http://www.ncbi.nlm.nih.gov/pubmed/28408357">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3554 href="http://dx.doi.org/10.5152/tjg.2017.050101">Publisher Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d66598e3563 class=n-a></a>Moretti R, Gazzin S, Crocè LS, <i> et al.</i>: Rapid identification system of frontal dysfunction in subclinical hepatic encephalopathy. <i>Ann Hepatol.</i> 2016; <b>15</b>(4): 559–67. <a target=xrefwindow id=d66598e3574 href="http://www.ncbi.nlm.nih.gov/pubmed/27236155">PubMed Abstract </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d66598e3584 class=n-a></a>Bajaj JS: Diagnosing minimal hepatic encephalopathy: from the ivory tower to the real world. <i>Gastroenterology.</i> 2015; <b>149</b>(6): 1330–3. <a target=xrefwindow id=d66598e3592 href="http://www.ncbi.nlm.nih.gov/pubmed/26416330">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3595 href="http://dx.doi.org/10.1053/j.gastro.2015.09.028">Publisher Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729074369"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e3604 class=n-a></a>Coskun B, Ozen M, Gursoy S, <i> et al.</i>: Normalization of the psychometric hepatic encephalopathy score for diagnosis of minimal hepatic encephalopathy in Turkey. <i>Niger J Clin Pract.</i> 2017; <b>20</b>(4): 421–6. <a target=xrefwindow id=d66598e3615 href="http://www.ncbi.nlm.nih.gov/pubmed/28406121">PubMed Abstract </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729074369">F1000 Recommendation</a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d66598e3628 class=n-a></a>Badea MA, Drug VL, Dranga M, <i> et al.</i>: Diagnosis of minimal hepatic encephalopathy in a tertiary care center from eastern Romania: validation of the psychometric hepatic encephalopathy score (PHES). <i>Metab Brain Dis.</i> 2016; <b>31</b>(6): 1463–71. <a target=xrefwindow id=d66598e3639 href="http://www.ncbi.nlm.nih.gov/pubmed/27461111">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3642 href="http://dx.doi.org/10.1007/s11011-016-9878-y">Publisher Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727212623"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e3651 class=n-a></a>Wuensch T, Ruether DF, Zöllner C, <i> et al.</i>: Performance characterization of a novel electronic number connection test to detect minimal hepatic encephalopathy in cirrhotic patients. <i>Eur J Gastroenterol Hepatol.</i> 2017; <b>29</b>(4): 456–63. <a target=xrefwindow id=d66598e3662 href="http://www.ncbi.nlm.nih.gov/pubmed/28092641">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3665 href="http://dx.doi.org/10.1097/MEG.0000000000000806">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727212623">F1000 Recommendation</a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729074370"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e3678 class=n-a></a>Özel Coşkun BD, Özen M: Critical flicker frequency test for diagnosing minimal hepatic encephalopathy in patients with cirrhosis. <i>Turk J Gastroenterol.</i> 2017; <b>28</b>(3): 191–6. <a target=xrefwindow id=d66598e3686 href="http://www.ncbi.nlm.nih.gov/pubmed/28316320">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3689 href="http://dx.doi.org/10.5152/tjg.2017.16618">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729074370">F1000 Recommendation</a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d66598e3702 class=n-a></a>Greinert R, Ripoll C, Hollenbach M, <i> et al.</i>: Stepwise diagnosis in covert hepatic encephalopathy: critical flicker frequency and MELD-score as a first-step approach. <i>Aliment Pharmacol Ther.</i> 2016; <b>44</b>(5): 514–21. <a target=xrefwindow id=d66598e3713 href="http://www.ncbi.nlm.nih.gov/pubmed/27385440">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3716 href="http://dx.doi.org/10.1111/apt.13721">Publisher Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d66598e3726 class=n-a></a>Martel-Laferrière V, Homberger C, Bichoupan K, <i> et al.</i>: MELD score and antibiotics use are predictors of length of stay in patients hospitalized with hepatic encephalopathy. <i>BMC Gastroenterol.</i> 2014; <b>14</b>: 185. <a target=xrefwindow id=d66598e3737 href="http://www.ncbi.nlm.nih.gov/pubmed/25326084">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3740 href="http://dx.doi.org/10.1186/1471-230X-14-185">Publisher Full Text </a> | <a target=xrefwindow id=d66598e3744 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4287486">Free Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725736376"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e3753 class=n-a></a>Ampuero J, Simón M, Montoliú C, <i> et al.</i>: Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis. <i>Gastroenterology.</i> 2015; <b>149</b>(6): 1483–9. <a target=xrefwindow id=d66598e3764 href="http://www.ncbi.nlm.nih.gov/pubmed/26299413">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3767 href="http://dx.doi.org/10.1053/j.gastro.2015.07.067">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725736376">F1000 Recommendation</a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d66598e3780 class=n-a></a>Bajaj JS: Adventures in Developing an App for Covert Hepatic Encephalopathy. <i>Clin Transl Gastroenterol.</i> 2017; <b>8</b>(4): e85. <a target=xrefwindow id=d66598e3788 href="http://www.ncbi.nlm.nih.gov/pubmed/28383566">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3791 href="http://dx.doi.org/10.1038/ctg.2017.14">Publisher Full Text </a> | <a target=xrefwindow id=d66598e3794 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5415896">Free Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725998848"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e3803 class=n-a></a>Allampati S, Duarte-Rojo A, Thacker LR, <i> et al.</i>: Diagnosis of Minimal Hepatic Encephalopathy Using Stroop EncephalApp: A Multicenter US-Based, Norm-Based Study. <i>Am J Gastroenterol.</i> 2016; <b>111</b>(1): 78–86. <a target=xrefwindow id=d66598e3814 href="http://www.ncbi.nlm.nih.gov/pubmed/26644276">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3817 href="http://dx.doi.org/10.1038/ajg.2015.377">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725998848">F1000 Recommendation</a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d66598e3830 class=n-a></a>Press CA, Morgan L, Mills M, <i> et al.</i>: Spectral Electroencephalogram Analysis for the Evaluation of Encephalopathy Grade in Children With Acute Liver Failure. <i>Pediatr Crit Care Med.</i> 2017; <b>18</b>(1): 64–72. <a target=xrefwindow id=d66598e3841 href="http://www.ncbi.nlm.nih.gov/pubmed/27811533">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3844 href="http://dx.doi.org/10.1097/PCC.0000000000001016">Publisher Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d66598e3853 class=n-a></a>Jackson CD, Gram M, Halliday E, <i> et al.</i>: New spectral thresholds improve the utility of the electroencephalogram for the diagnosis of hepatic encephalopathy. <i>Clin Neurophysiol.</i> 2016; <b>127</b>(8): 2933–41. <a target=xrefwindow id=d66598e3864 href="http://www.ncbi.nlm.nih.gov/pubmed/27236607">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3867 href="http://dx.doi.org/10.1016/j.clinph.2016.03.027">Publisher Full Text </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d66598e3877 class=n-a></a>Olesen SS, Gram M, Jackson CD, <i> et al.</i>: Electroencephalogram variability in patients with cirrhosis associates with the presence and severity of hepatic encephalopathy. <i>J Hepatol.</i> 2016; <b>65</b>(3): 517–23. <a target=xrefwindow id=d66598e3888 href="http://www.ncbi.nlm.nih.gov/pubmed/27184531">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3891 href="http://dx.doi.org/10.1016/j.jhep.2016.05.004">Publisher Full Text </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726113456"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e3900 class=n-a></a>Schiff S, Casa M, Di Caro V, <i> et al.</i>: A low-cost, user-friendly electroencephalographic recording system for the assessment of hepatic encephalopathy. <i>Hepatology.</i> 2016; <b>63</b>(5): 1651–9. <a target=xrefwindow id=d66598e3911 href="http://www.ncbi.nlm.nih.gov/pubmed/26833704">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3914 href="http://dx.doi.org/10.1002/hep.28477">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726113456">F1000 Recommendation</a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a name=d66598e3927 class=n-a></a>Scheau C, Dinu R, Tarta-Arsene E, <i> et al.</i>: Current Stance of Magnetic Resonance Imaging in the Diagnosis and Monitoring of Hepatic Encephalopathy. <i>Maedica (Buchar).</i> 2015; <b>10</b>(3): 243–7. <a target=xrefwindow id=d66598e3938 href="http://www.ncbi.nlm.nih.gov/pubmed/28261361">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3941 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5327831">Free Full Text </a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d66598e3950 class=n-a></a>Li Y, Liu H, Yang J, <i> et al.</i>: Combining arterial-spin labeling with functional magnetic resonance imaging measurement for characterizing patients with minimal hepatic encephalopathy. <i>Hepatol Res.</i> 2017; <b>47</b>(9): 862–71. <a target=xrefwindow id=d66598e3961 href="http://www.ncbi.nlm.nih.gov/pubmed/27717156">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3964 href="http://dx.doi.org/10.1111/hepr.12827">Publisher Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726316957"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e3973 class=n-a></a>Yadav SK, Goel A, Saraswat VA, <i> et al.</i>: Evaluation of cognitivity, proinflammatory cytokines, and brain magnetic resonance imaging in minimal hepatic encephalopathy induced by cirrhosis and extrahepatic portal vein obstruction. <i>J Gastroenterol Hepatol.</i> 2016; <b>31</b>(12): 1986–94. <a target=xrefwindow id=d66598e3984 href="http://www.ncbi.nlm.nih.gov/pubmed/27119420">PubMed Abstract </a> | <a target=xrefwindow id=d66598e3987 href="http://dx.doi.org/10.1111/jgh.13427">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726316957">F1000 Recommendation</a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d66598e4000 class=n-a></a>Chen HJ, Zhang L, Jiang LF, <i> et al.</i>: Identifying minimal hepatic encephalopathy in cirrhotic patients by measuring spontaneous brain activity. <i>Metab Brain Dis.</i> 2016; <b>31</b>(4): 761–9. <a target=xrefwindow id=d66598e4011 href="http://www.ncbi.nlm.nih.gov/pubmed/26886109">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4014 href="http://dx.doi.org/10.1007/s11011-016-9799-9">Publisher Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a name=d66598e4024 class=n-a></a>Zhong WJ, Zhou ZM, Zhao JN, <i> et al.</i>: Abnormal spontaneous brain activity in minimal hepatic encephalopathy: resting-state fMRI study. <i>Diagn Interv Radiol.</i> 2016; <b>22</b>(2): 196–200. <a target=xrefwindow id=d66598e4035 href="http://www.ncbi.nlm.nih.gov/pubmed/26742646">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4038 href="http://dx.doi.org/10.5152/dir.2015.15208">Publisher Full Text </a> | <a target=xrefwindow id=d66598e4042 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4790075">Free Full Text </a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729074371"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e4051 class=n-a></a>Or M, Peremans K, Martlé V, <i> et al.</i>: Regional cerebral blood flow assessed by single photon emission computed tomography (SPECT) in dogs with congenital portosystemic shunt and hepatic encephalopathy. <i>Vet J.</i> 2017; <b>220</b>: 40–2. <a target=xrefwindow id=d66598e4062 href="http://www.ncbi.nlm.nih.gov/pubmed/28190492">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4065 href="http://dx.doi.org/10.1016/j.tvjl.2016.12.009">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729074371">F1000 Recommendation</a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726766516"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e4078 class=n-a></a>McPhail MJ, Montagnese S, Villanova M, <i> et al.</i>: Urinary metabolic profiling by <sup>1</sup>H NMR spectroscopy in patients with cirrhosis may discriminate overt but not covert hepatic encephalopathy. <i>Metab Brain Dis.</i> 2017; <b>32</b>(2): 331–41. <a target=xrefwindow id=d66598e4092 href="http://www.ncbi.nlm.nih.gov/pubmed/27638475">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4096 href="http://dx.doi.org/10.1007/s11011-016-9904-0">Publisher Full Text </a> | <a target=xrefwindow id=d66598e4099 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5346407">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726766516">F1000 Recommendation</a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a name=d66598e4112 class=n-a></a>Betrapally NS, Gillevet PM, Bajaj JS: Gut microbiome and liver disease. <i>Transl Res.</i> 2017; <b>179</b>: 49–59. <a target=xrefwindow id=d66598e4120 href="http://www.ncbi.nlm.nih.gov/pubmed/27477080">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4123 href="http://dx.doi.org/10.1016/j.trsl.2016.07.005">Publisher Full Text </a> | <a target=xrefwindow id=d66598e4126 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5164947">Free Full Text </a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a name=d66598e4135 class=n-a></a>Shawcross DL: Is it time to target gut dysbiosis and immune dysfunction in the therapy of hepatic encephalopathy? <i>Expert Rev Gastroenterol Hepatol.</i> 2015; <b>9</b>(5): 539–42. <a target=xrefwindow id=d66598e4143 href="http://www.ncbi.nlm.nih.gov/pubmed/25846450">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4146 href="http://dx.doi.org/10.1586/17474124.2015.1035257">Publisher Full Text </a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a name=d66598e4155 class=n-a></a>Dam G, Vilstrup H, Watson H, <i> et al.</i>: Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites. <i>Hepatology.</i> 2016; <b>64</b>(4): 1265–72. <a target=xrefwindow id=d66598e4166 href="http://www.ncbi.nlm.nih.gov/pubmed/27474889">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4169 href="http://dx.doi.org/10.1002/hep.28737">Publisher Full Text </a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a name=d66598e4179 class=n-a></a>Lachar J, Bajaj JS: Changes in the Microbiome in Cirrhosis and Relationship to Complications: Hepatic Encephalopathy, Spontaneous Bacterial Peritonitis, and Sepsis. <i>Semin Liver Dis.</i> 2016; <b>36</b>(4): 327–30. <a target=xrefwindow id=d66598e4187 href="http://www.ncbi.nlm.nih.gov/pubmed/27997972">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4190 href="http://dx.doi.org/10.1055/s-0036-1593881">Publisher Full Text </a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a name=d66598e4199 class=n-a></a>Rai R, Saraswat VA, Dhiman RK: Gut microbiota: its role in hepatic encephalopathy. <i>J Clin Exp Hepatol.</i> 2015; <b>5</b>(Suppl 1): S29–36. <a target=xrefwindow id=d66598e4207 href="http://www.ncbi.nlm.nih.gov/pubmed/26041954">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4210 href="http://dx.doi.org/10.1016/j.jceh.2014.12.003">Publisher Full Text </a> | <a target=xrefwindow id=d66598e4213 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4442863">Free Full Text </a></span></li><li><a name=ref-110 class=n-a></a><span class=label>110. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727566796"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e4222 class=n-a></a>Bian J, Wang A, Lin J, <i> et al.</i>: Association between proton pump inhibitors and hepatic encephalopathy: A meta-analysis. <i>Medicine (Baltimore).</i> 2017; <b>96</b>(17): e6723. <a target=xrefwindow id=d66598e4233 href="http://www.ncbi.nlm.nih.gov/pubmed/28445288">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4236 href="http://dx.doi.org/10.1097/MD.0000000000006723">Publisher Full Text </a> | <a target=xrefwindow id=d66598e4240 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5413253">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727566796">F1000 Recommendation</a></span></li><li><a name=ref-111 class=n-a></a><span class=label>111. </span>&nbsp;<span class=citation><a name=d66598e4253 class=n-a></a>Khan MA, Cholankeril G, Howden CW: Proton Pump Inhibitors and the Possible Development of Hepatic Encephalopathy in Cirrhotic Patients: True Association or Residual Confounding? <i>Gastroenterology.</i> 2017; <b>152</b>(8): 2076. <a target=xrefwindow id=d66598e4261 href="http://www.ncbi.nlm.nih.gov/pubmed/28478154">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4264 href="http://dx.doi.org/10.1053/j.gastro.2016.10.050">Publisher Full Text </a></span></li><li><a name=ref-112 class=n-a></a><span class=label>112. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726749152"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e4273 class=n-a></a>Tsai CF, Chen MH, Wang YP, <i> et al.</i>: Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study. <i>Gastroenterology.</i> 2017; <b>152</b>(1): 134–41. <a target=xrefwindow id=d66598e4284 href="http://www.ncbi.nlm.nih.gov/pubmed/27639806">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4287 href="http://dx.doi.org/10.1053/j.gastro.2016.09.007">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726749152">F1000 Recommendation</a></span></li><li><a name=ref-113 class=n-a></a><span class=label>113. </span>&nbsp;<span class=citation><a name=d66598e4300 class=n-a></a>Sharma BC, Singh J: Probiotics in management of hepatic encephalopathy. <i>Metab Brain Dis.</i> 2016; <b>31</b>(6): 1295–301. <a target=xrefwindow id=d66598e4308 href="http://www.ncbi.nlm.nih.gov/pubmed/27121846">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4311 href="http://dx.doi.org/10.1007/s11011-016-9826-x">Publisher Full Text </a></span></li><li><a name=ref-114 class=n-a></a><span class=label>114. </span>&nbsp;<span class=citation><a name=d66598e4321 class=n-a></a>Zhao LN, Yu T, Lan SY, <i> et al.</i>: Probiotics can improve the clinical outcomes of hepatic encephalopathy: An update meta-analysis. <i>Clin Res Hepatol Gastroenterol.</i> 2015; <b>39</b>(6): 674–82. <a target=xrefwindow id=d66598e4332 href="http://www.ncbi.nlm.nih.gov/pubmed/25956487">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4335 href="http://dx.doi.org/10.1016/j.clinre.2015.03.008">Publisher Full Text </a></span></li><li><a name=ref-115 class=n-a></a><span class=label>115. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725931969"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e4344 class=n-a></a>Saab S, Suraweera D, Au J, <i> et al.</i>: Probiotics are helpful in hepatic encephalopathy: a meta-analysis of randomized trials. <i>Liver Int.</i> 2016; <b>36</b>(7): 986–93. <a target=xrefwindow id=d66598e4355 href="http://www.ncbi.nlm.nih.gov/pubmed/26561214">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4358 href="http://dx.doi.org/10.1111/liv.13005">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725931969">F1000 Recommendation</a></span></li><li><a name=ref-116 class=n-a></a><span class=label>116. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727337504"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e4371 class=n-a></a>Dalal R, McGee RG, Riordan SM, <i> et al.</i>: Probiotics for people with hepatic encephalopathy. <i>Cochrane Database Syst Rev.</i> 2017; <b>2</b>: CD008716. <a target=xrefwindow id=d66598e4382 href="http://www.ncbi.nlm.nih.gov/pubmed/28230908">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4385 href="http://dx.doi.org/10.1002/14651858.CD008716.pub3">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727337504">F1000 Recommendation</a></span></li><li><a name=ref-117 class=n-a></a><span class=label>117. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718896656"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e4398 class=n-a></a>Pratap Mouli V, Benjamin J, Bhushan Singh M, <i> et al.</i>: Effect of probiotic VSL#3 in the treatment of minimal hepatic encephalopathy: A non-inferiority randomized controlled trial. <i>Hepatol Res.</i> 2015; <b>45</b>(8): 880–9. <a target=xrefwindow id=d66598e4409 href="http://www.ncbi.nlm.nih.gov/pubmed/25266207">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4412 href="http://dx.doi.org/10.1111/hepr.12429">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718896656">F1000 Recommendation</a></span></li><li><a name=ref-118 class=n-a></a><span class=label>118. </span>&nbsp;<span class=citation><a name=d66598e4425 class=n-a></a>Shavakhi A, Hashemi H, Tabesh E, <i> et al.</i>: Multistrain probiotic and lactulose in the treatment of minimal hepatic encephalopathy. <i>J Res Med Sci.</i> 2014; <b>19</b>(8): 703–8. <a target=xrefwindow id=d66598e4436 href="http://www.ncbi.nlm.nih.gov/pubmed/25422653">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4439 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4235088">Free Full Text </a></span></li><li><a name=ref-119 class=n-a></a><span class=label>119. </span>&nbsp;<span class=citation><a name=d66598e4448 class=n-a></a>Dhiman RK, Rana B, Agrawal S, <i> et al.</i>: Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial. <i>Gastroenterology.</i> 2014; <b>147</b>(6): 1327–37.e3. <a target=xrefwindow id=d66598e4459 href="http://www.ncbi.nlm.nih.gov/pubmed/25450083">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4462 href="http://dx.doi.org/10.1053/j.gastro.2014.08.031">Publisher Full Text </a></span></li><li><a name=ref-120 class=n-a></a><span class=label>120. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725844075"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e4472 class=n-a></a>Maharshi S, Sharma BC, Sachdeva S, <i> et al.</i>: Efficacy of Nutritional Therapy for Patients With Cirrhosis and Minimal Hepatic Encephalopathy in a Randomized Trial. <i>Clin Gastroenterol Hepatol.</i> 2016; <b>14</b>(3): 454–460.e3; quiz e33. <a target=xrefwindow id=d66598e4483 href="http://www.ncbi.nlm.nih.gov/pubmed/26453952">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4486 href="http://dx.doi.org/10.1016/j.cgh.2015.09.028">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725844075">F1000 Recommendation</a></span></li><li><a name=ref-121 class=n-a></a><span class=label>121. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/723874139"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e4499 class=n-a></a>Bajaj JS, Barrett AC, Bortey E, <i> et al.</i>: Prolonged remission from hepatic encephalopathy with rifaximin: results of a placebo crossover analysis. <i>Aliment Pharmacol Ther.</i> 2015; <b>41</b>(1): 39–45. <a target=xrefwindow id=d66598e4510 href="http://www.ncbi.nlm.nih.gov/pubmed/25339518">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4513 href="http://dx.doi.org/10.1111/apt.12993">Publisher Full Text </a> | <a target=xrefwindow id=d66598e4517 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4284039">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/723874139">F1000 Recommendation</a></span></li><li><a name=ref-122 class=n-a></a><span class=label>122. </span>&nbsp;<span class=citation><a name=d66598e4530 class=n-a></a>Tapper EB: Rifaximin for the prevention of readmissions for patients with hepatic encephalopathy - the price is right. <i>Liver Int.</i> 2016; <b>36</b>(9): 1252–4. <a target=xrefwindow id=d66598e4538 href="http://www.ncbi.nlm.nih.gov/pubmed/27507251">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4541 href="http://dx.doi.org/10.1111/liv.13130">Publisher Full Text </a></span></li><li><a name=ref-123 class=n-a></a><span class=label>123. </span>&nbsp;<span class=citation><a name=d66598e4550 class=n-a></a>Whitehouse JT, Berni E, Conway P, <i> et al.</i>: Evaluation of The Cost Effectiveness and Societal Impact of Rifaximin-Á 550mg In The Reduction of Recurrence of Overt Hepatic Encephalopathy In The Netherlands. <i>Value Health.</i> 2015; <b>18</b>(7): A629. <a target=xrefwindow id=d66598e4561 href="http://www.ncbi.nlm.nih.gov/pubmed/26533529">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4564 href="http://dx.doi.org/10.1016/j.jval.2015.09.2219">Publisher Full Text </a></span></li><li><a name=ref-124 class=n-a></a><span class=label>124. </span>&nbsp;<span class=citation><a name=d66598e4573 class=n-a></a>Berni E, Connolly M, Conway P, <i> et al.</i>: Evaluation of The Cost Effectiveness of Rifaximin-Á In The Reduction of Recurrence of Overt Hepatic Encephalopathy In Belgium. <i>Value Health.</i> 2015; <b>18</b>(7): A628. <a target=xrefwindow id=d66598e4584 href="http://www.ncbi.nlm.nih.gov/pubmed/26533525">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4587 href="http://dx.doi.org/10.1016/j.jval.2015.09.2216">Publisher Full Text </a></span></li><li><a name=ref-125 class=n-a></a><span class=label>125. </span>&nbsp;<span class=citation><a name=d66598e4596 class=n-a></a>Berni E, Poole CD, Conway P, <i> et al.</i>: Cost Effectiveness of Rifaximin-Á 550mg In The Reduction of Recurrence of Overt Hepatic Encephalopathy In United Kingdom. <i>Value Health.</i> 2015; <b>18</b>(7): A626. <a target=xrefwindow id=d66598e4607 href="http://www.ncbi.nlm.nih.gov/pubmed/26533513">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4610 href="http://dx.doi.org/10.1016/j.jval.2015.09.2206">Publisher Full Text </a></span></li><li><a name=ref-126 class=n-a></a><span class=label>126. </span>&nbsp;<span class=citation><a name=d66598e4620 class=n-a></a>Poole CD, Berni E, Conway P, <i> et al.</i>: Evaluation of The Cost Effectiveness of Rifaximin-á 550mg In The Reduction of Recurrence of Overt Hepatic Encephalopathy In Sweden. <i>Value Health.</i> 2015; <b>18</b>(7): A626. <a target=xrefwindow id=d66598e4631 href="http://www.ncbi.nlm.nih.gov/pubmed/26533517">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4634 href="http://dx.doi.org/10.1016/j.jval.2015.09.2202">Publisher Full Text </a></span></li><li><a name=ref-127 class=n-a></a><span class=label>127. </span>&nbsp;<span class=citation><a name=d66598e4643 class=n-a></a>Bajaj JS, Heuman DM, Sanyal AJ, <i> et al.</i>: Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy. <i>PLoS One.</i> 2013; <b>8</b>(4): e60042. <a target=xrefwindow id=d66598e4654 href="http://www.ncbi.nlm.nih.gov/pubmed/23565181">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4657 href="http://dx.doi.org/10.1371/journal.pone.0060042">Publisher Full Text </a> | <a target=xrefwindow id=d66598e4661 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3615021">Free Full Text </a></span></li><li><a name=ref-128 class=n-a></a><span class=label>128. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727291251"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e4670 class=n-a></a>Lyon KC, Likar E, Martello JL, <i> et al.</i>: Retrospective Cross-Sectional Pilot Study of Rifaximin Dosing for the Prevention of Recurrent Hepatic Encephalopathy. <i>J Gastroenterol Hepatol.</i> 2017. <a target=xrefwindow id=d66598e4678 href="http://www.ncbi.nlm.nih.gov/pubmed/28177545">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4681 href="http://dx.doi.org/10.1111/jgh.13759">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727291251">F1000 Recommendation</a></span></li><li><a name=ref-129 class=n-a></a><span class=label>129. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726613176"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e4694 class=n-a></a>Kabeshova A, Ben Hariz S, Tsakeu E, <i> et al.</i>: Cost-effectiveness analysis of rifaximin-α administration for the reduction of episodes of overt hepatic encephalopathy in recurrence compared with standard treatment in France. <i>Therap Adv Gastroenterol.</i> 2016; <b>9</b>(4): 473–82. <a target=xrefwindow id=d66598e4705 href="http://www.ncbi.nlm.nih.gov/pubmed/27366216">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4708 href="http://dx.doi.org/10.1177/1756283X16644249">Publisher Full Text </a> | <a target=xrefwindow id=d66598e4712 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4913340">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726613176">F1000 Recommendation</a></span></li><li><a name=ref-130 class=n-a></a><span class=label>130. </span>&nbsp;<span class=citation><a name=d66598e4725 class=n-a></a>Courson A, Jones GM, Twilla JD: Treatment of Acute Hepatic Encephalopathy: <i>Comparing the Effects of Adding Rifaximin to Lactulose on Patient Outcomes</i>. <i>J Pharm Pract.</i> 2016; <b>29</b>(3): 212–7. <a target=xrefwindow id=d66598e4736 href="http://www.ncbi.nlm.nih.gov/pubmed/25586470">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4739 href="http://dx.doi.org/10.1177/0897190014566312">Publisher Full Text </a></span></li><li><a name=ref-131 class=n-a></a><span class=label>131. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726490324"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e4748 class=n-a></a>Moratalla A, Ampuero J, Bellot P, <i> et al.</i>: Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy. <i>Liver Int.</i> 2017; <b>37</b>(2): 212–23. <a target=xrefwindow id=d66598e4759 href="http://www.ncbi.nlm.nih.gov/pubmed/27388776">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4762 href="http://dx.doi.org/10.1111/liv.13200">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726490324">F1000 Recommendation</a></span></li><li><a name=ref-132 class=n-a></a><span class=label>132. </span>&nbsp;<span class=citation><a name=d66598e4776 class=n-a></a>Ventura-Cots M, Arranz JA, Simón-Talero M, <i> et al.</i>: Safety of ornithine phenylacetate in cirrhotic decompensated patients: an open-label, dose-escalating, single-cohort study. <i>J Clin Gastroenterol.</i> 2013; <b>47</b>(10): 881–7. <a target=xrefwindow id=d66598e4787 href="http://www.ncbi.nlm.nih.gov/pubmed/23751856">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4790 href="http://dx.doi.org/10.1097/MCG.0b013e318299c789">Publisher Full Text </a></span></li><li><a name=ref-133 class=n-a></a><span class=label>133. </span>&nbsp;<span class=citation><a name=d66598e4799 class=n-a></a>Ventura-Cots M, Concepción M, Arranz JA, <i> et al.</i>: Impact of ornithine phenylacetate (OCR-002) in lowering plasma ammonia after upper gastrointestinal bleeding in cirrhotic patients. <i>Therap Adv Gastroenterol.</i> 2016; <b>9</b>(6): 823–35. <a target=xrefwindow id=d66598e4810 href="http://www.ncbi.nlm.nih.gov/pubmed/27803737">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4813 href="http://dx.doi.org/10.1177/1756283X16658252">Publisher Full Text </a> | <a target=xrefwindow id=d66598e4817 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5076769">Free Full Text </a></span></li><li><a name=ref-134 class=n-a></a><span class=label>134. </span>&nbsp;<span class=citation><a name=d66598e4826 class=n-a></a>Kristiansen RG: Current state of knowledge of hepatic encephalopathy (part I): newer treatment strategies for hyperammonemia in liver failure. <i>Metab Brain Dis.</i> 2016; <b>31</b>(6): 1357–8. <a target=xrefwindow id=d66598e4834 href="http://www.ncbi.nlm.nih.gov/pubmed/27651377">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4837 href="http://dx.doi.org/10.1007/s11011-016-9908-9">Publisher Full Text </a></span></li><li><a name=ref-135 class=n-a></a><span class=label>135. </span>&nbsp;<span class=citation><a name=d66598e4846 class=n-a></a>Sharma K, Pant S, Misra S, <i> et al.</i>: Effect of rifaximin, probiotics, and l-ornithine l-aspartate on minimal hepatic encephalopathy: a randomized controlled trial. <i>Saudi J Gastroenterol.</i> 2014; <b>20</b>(4): 225–32. <a target=xrefwindow id=d66598e4857 href="http://www.ncbi.nlm.nih.gov/pubmed/25038208">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4860 href="http://dx.doi.org/10.4103/1319-3767.136975">Publisher Full Text </a> | <a target=xrefwindow id=d66598e4864 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4131305">Free Full Text </a></span></li><li><a name=ref-136 class=n-a></a><span class=label>136. </span>&nbsp;<span class=citation><a name=d66598e4873 class=n-a></a>Grover VP, McPhail MJ, Wylezinska-Arridge M, <i> et al.</i>: A longitudinal study of patients with cirrhosis treated with L-ornithine L-aspartate, examined with magnetization transfer, diffusion-weighted imaging and magnetic resonance spectroscopy. <i>Metab Brain Dis.</i> 2017; <b>32</b>(1): 77–86. <a target=xrefwindow id=d66598e4884 href="http://www.ncbi.nlm.nih.gov/pubmed/27488112">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4887 href="http://dx.doi.org/10.1007/s11011-016-9881-3">Publisher Full Text </a> | <a target=xrefwindow id=d66598e4891 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5225223">Free Full Text </a></span></li><li><a name=ref-137 class=n-a></a><span class=label>137. </span>&nbsp;<span class=citation><a name=d66598e4900 class=n-a></a>Sidhu SS, Sharma BC, Goyal O, <i> et al.</i>: L-ornithine L-aspartate in bouts of overt hepatic encephalopathy. <i>Hepatology.</i> 2017. <a target=xrefwindow id=d66598e4908 href="http://www.ncbi.nlm.nih.gov/pubmed/28749571">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4911 href="http://dx.doi.org/10.1002/hep.29410">Publisher Full Text </a></span></li><li><a name=ref-138 class=n-a></a><span class=label>138. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729074377"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e4921 class=n-a></a>Naderian M, Akbari H, Saeedi M, <i> et al.</i>: Polyethylene Glycol and Lactulose versus Lactulose Alone in the Treatment of Hepatic Encephalopathy in Patients with Cirrhosis: A Non-Inferiority Randomized Controlled Trial. <i>Middle East J Dig Dis.</i> 2017; <b>9</b>(1): 12–9. <a target=xrefwindow id=d66598e4932 href="http://www.ncbi.nlm.nih.gov/pubmed/28316761">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4935 href="http://dx.doi.org/10.15171/mejdd.2016.46">Publisher Full Text </a> | <a target=xrefwindow id=d66598e4939 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5308129">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729074377">F1000 Recommendation</a></span></li><li><a name=ref-139 class=n-a></a><span class=label>139. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718889452"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e4952 class=n-a></a>Rahimi RS, Singal AG, Cuthbert JA, <i> et al.</i>: Lactulose vs polyethylene glycol 3350--electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomized clinical trial. <i>JAMA Intern Med.</i> 2014; <b>174</b>(11): 1727–33. <a target=xrefwindow id=d66598e4963 href="http://www.ncbi.nlm.nih.gov/pubmed/25243839">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4966 href="http://dx.doi.org/10.1001/jamainternmed.2014.4746">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718889452">F1000 Recommendation</a></span></li><li><a name=ref-140 class=n-a></a><span class=label>140. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727022936"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e4979 class=n-a></a>Sharma BC, Singh J, Srivastava S, <i> et al.</i>: Randomized controlled trial comparing lactulose plus albumin versus lactulose alone for treatment of hepatic encephalopathy. <i>J Gastroenterol Hepatol.</i> 2017; <b>32</b>(6): 1234–9. <a target=xrefwindow id=d66598e4990 href="http://www.ncbi.nlm.nih.gov/pubmed/27885712">PubMed Abstract </a> | <a target=xrefwindow id=d66598e4993 href="http://dx.doi.org/10.1111/jgh.13666">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727022936">F1000 Recommendation</a></span></li><li><a name=ref-141 class=n-a></a><span class=label>141. </span>&nbsp;<span class=citation><a name=d66598e5006 class=n-a></a>Tajiri K, Shimizu Y: Branched-chain amino acids in liver diseases. <i>World J Gastroenterol.</i> 2013; <b>19</b>(43): 7620–9. <a target=xrefwindow id=d66598e5014 href="http://www.ncbi.nlm.nih.gov/pubmed/24282351">PubMed Abstract </a> | <a target=xrefwindow id=d66598e5017 href="http://dx.doi.org/10.3748/wjg.v19.i43.7620">Publisher Full Text </a> | <a target=xrefwindow id=d66598e5020 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3837260">Free Full Text </a></span></li><li><a name=ref-142 class=n-a></a><span class=label>142. </span>&nbsp;<span class=citation><a name=d66598e5029 class=n-a></a>Vergara M, Castro-Gutiérrez V, Rada G: Do branched chain amino acids improve hepatic encephalopathy in cirrhosis? <i>Medwave.</i> 2016; <b>16</b>(Suppl5): e6795. <a target=xrefwindow id=d66598e5037 href="http://www.ncbi.nlm.nih.gov/pubmed/28024140">PubMed Abstract </a> | <a target=xrefwindow id=d66598e5040 href="http://dx.doi.org/10.5867/medwave.2016.6795">Publisher Full Text </a></span></li><li><a name=ref-143 class=n-a></a><span class=label>143. </span>&nbsp;<span class=citation><a name=d66598e5049 class=n-a></a>Gluud LL, Dam G, Les I, <i> et al.</i>: Branched-chain amino acids for people with hepatic encephalopathy. <i>Cochrane Database Syst Rev.</i> 2015; <b>5</b>: CD001939. <a target=xrefwindow id=d66598e5060 href="http://www.ncbi.nlm.nih.gov/pubmed/28518283">PubMed Abstract </a> | <a target=xrefwindow id=d66598e5063 href="http://dx.doi.org/10.1002/14651858.CD001939.pub4">Publisher Full Text </a></span></li><li><a name=ref-144 class=n-a></a><span class=label>144. </span>&nbsp;<span class=citation><a name=d66598e5073 class=n-a></a>Ruiz-Margáin A, Macías-Rodríguez RU, Ríos-Torres SL, <i> et al.</i>: Effect of a high-protein, high-fiber diet plus supplementation with branched-chain amino acids on the nutritional status of patients with cirrhosis. <i>Rev Gastroenterol Mex.</i> 2017; pii: S0375-0906(17)30060-5. <a target=xrefwindow id=d66598e5081 href="http://www.ncbi.nlm.nih.gov/pubmed/28408059">PubMed Abstract </a> | <a target=xrefwindow id=d66598e5084 href="http://dx.doi.org/10.1016/j.rgmx.2017.02.005">Publisher Full Text </a></span></li><li><a name=ref-145 class=n-a></a><span class=label>145. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727201590"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e5093 class=n-a></a>Kakisaka K, Kataoka K, Suzuki Y, <i> et al.</i>: Appropriate timing to start and optimal response evaluation of high-dose corticosteroid therapy for patients with acute liver failure. <i>J Gastroenterol.</i> 2017; <b>52</b>(8): 977–85. <a target=xrefwindow id=d66598e5104 href="http://www.ncbi.nlm.nih.gov/pubmed/28078470">PubMed Abstract </a> | <a target=xrefwindow id=d66598e5107 href="http://dx.doi.org/10.1007/s00535-017-1306-5">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727201590">F1000 Recommendation</a></span></li><li><a name=ref-146 class=n-a></a><span class=label>146. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729074378"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e5120 class=n-a></a>Zhang G, Cheng Y, Shen W, <i> et al.</i>: The short-term effect of liver transplantation on the low-frequency fluctuation of brain activity in cirrhotic patients with and without overt hepatic encephalopathy. <i>Brain Imaging Behav.</i> 2016; 1–13. <a target=xrefwindow id=d66598e5128 href="http://www.ncbi.nlm.nih.gov/pubmed/27917450">PubMed Abstract </a> | <a target=xrefwindow id=d66598e5131 href="http://dx.doi.org/10.1007/s11682-016-9659-6">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729074378">F1000 Recommendation</a></span></li><li><a name=ref-147 class=n-a></a><span class=label>147. </span>&nbsp;<span class=citation><a name=d66598e5144 class=n-a></a>Brader RA, Kim KR: Transhepatic embolization of a congenital intrahepatic portosystemic shunt for the treatment of hepatic encephalopathy in a noncirrhotic patient using Amplatzer vascular plug device. <i>Radiol Case Rep.</i> 2017; <b>12</b>(2): 318–22. <a target=xrefwindow id=d66598e5152 href="http://www.ncbi.nlm.nih.gov/pubmed/28491179">PubMed Abstract </a> | <a target=xrefwindow id=d66598e5155 href="http://dx.doi.org/10.1016/j.radcr.2016.12.006">Publisher Full Text </a> | <a target=xrefwindow id=d66598e5158 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5417625">Free Full Text </a></span></li><li><a name=ref-148 class=n-a></a><span class=label>148. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729074380"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e5167 class=n-a></a>Ishikawa T, Imai M, Ko M, <i> et al.</i>: Percutaneous transhepatic obliteration and percutaneous transhepatic sclerotherapy for intractable hepatic encephalopathy and gastric varices improves the hepatic function reserve. <i>Biomed Rep.</i> 2017; <b>6</b>(1): 99–102. <a target=xrefwindow id=d66598e5178 href="http://www.ncbi.nlm.nih.gov/pubmed/28123716">PubMed Abstract </a> | <a target=xrefwindow id=d66598e5181 href="http://dx.doi.org/10.3892/br.2016.811">Publisher Full Text </a> | <a target=xrefwindow id=d66598e5185 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5244787">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729074380">F1000 Recommendation</a></span></li><li><a name=ref-149 class=n-a></a><span class=label>149. </span>&nbsp;<span class=citation><a name=d66598e5198 class=n-a></a>Routhu M, Safka V, Routhu SK, <i> et al.</i>: Observational cohort study of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS). <i>Ann Hepatol.</i> 2017; <b>16</b>(1): 140–8. <a target=xrefwindow id=d66598e5209 href="http://www.ncbi.nlm.nih.gov/pubmed/28051803">PubMed Abstract </a> | <a target=xrefwindow id=d66598e5212 href="http://dx.doi.org/10.5604/16652681.1226932">Publisher Full Text </a></span></li><li><a name=ref-150 class=n-a></a><span class=label>150. </span>&nbsp;<span class=citation><a name=d66598e5222 class=n-a></a>Wang CM, Li X, Fu J, <i> et al.</i>: Construction of Transjugular Intrahepatic Portosystemic Shunt: Bare Metal Stent/Stent-graft Combination versus Single Stent-graft, a Prospective Randomized Controlled Study with Long-term Patency and Clinical Analysis. <i>Chin Med J (Engl).</i> 2016; <b>129</b>(11): 1261–7. <a target=xrefwindow id=d66598e5233 href="http://www.ncbi.nlm.nih.gov/pubmed/27231160">PubMed Abstract </a> | <a target=xrefwindow id=d66598e5236 href="http://dx.doi.org/10.4103/0366-6999.182830">Publisher Full Text </a> | <a target=xrefwindow id=d66598e5240 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4894033">Free Full Text </a></span></li><li><a name=ref-151 class=n-a></a><span class=label>151. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727244706"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e5249 class=n-a></a>Miraglia R, Maruzzelli L, Tuzzolino F, <i> et al.</i>: Transjugular Intrahepatic Portosystemic Shunts in Patients with Cirrhosis with Refractory Ascites: Comparison of Clinical Outcomes by Using 8- and 10-mm PTFE-covered Stents. <i>Radiology.</i> 2017; <b>284</b>(1): 281–8. <a target=xrefwindow id=d66598e5260 href="http://www.ncbi.nlm.nih.gov/pubmed/28121521">PubMed Abstract </a> | <a target=xrefwindow id=d66598e5263 href="http://dx.doi.org/10.1148/radiol.2017161644">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727244706">F1000 Recommendation</a></span></li><li><a name=ref-152 class=n-a></a><span class=label>152. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729074383"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e5276 class=n-a></a>Borghol S, Perarnau JM, Pucheux J, <i> et al.</i>: Short- and long-term evolution of the endoluminal diameter of underdilated stents in transjugular intrahepatic portosystemic shunt. <i>Diagn Interv Imaging.</i> 2016; <b>97</b>(11): 1103–7. <a target=xrefwindow id=d66598e5287 href="http://www.ncbi.nlm.nih.gov/pubmed/27423709">PubMed Abstract </a> | <a target=xrefwindow id=d66598e5290 href="http://dx.doi.org/10.1016/j.diii.2016.06.008">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729074383">F1000 Recommendation</a></span></li><li><a name=ref-153 class=n-a></a><span class=label>153. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729074384"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e5303 class=n-a></a>Luo L, Fu S, Zhang Y, <i> et al.</i>: Early diet intervention to reduce the incidence of hepatic encephalopathy in cirrhosis patients: post-Transjugular Intrahepatic Portosystemic Shunt (TIPS) findings. <i>Asia Pac J Clin Nutr.</i> 2016; <b>25</b>(3): 497–503. <a target=xrefwindow id=d66598e5314 href="http://dx.doi.org/10.6133/apjcn.092015.14">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729074384">F1000 Recommendation</a></span></li><li><a name=ref-154 class=n-a></a><span class=label>154. </span>&nbsp;<span class=citation><a name=d66598e5327 class=n-a></a>Doshi M, Pereira K, Carrion A, <i> et al.</i>: Antegrade embolization of spontaneous splenorenal shunt for post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy. <i>Hepatology.</i> 2016; <b>64</b>(1): 314–5. <a target=xrefwindow id=d66598e5338 href="http://www.ncbi.nlm.nih.gov/pubmed/26566759">PubMed Abstract </a> | <a target=xrefwindow id=d66598e5341 href="http://dx.doi.org/10.1002/hep.28343">Publisher Full Text </a></span></li><li><a name=ref-155 class=n-a></a><span class=label>155. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/729074385"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d66598e5350 class=n-a></a>Mukund A, Deogaonkar G, Rajesh S, <i> et al.</i>: Safety and Efficacy of Sodium Tetradecyl Sulfate and Lipiodol Foam in Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for Large Porto-Systemic Shunts. <i>Cardiovasc Intervent Radiol.</i> 2017; <b>40</b>(7): 1010–6. <a target=xrefwindow id=d66598e5361 href="http://www.ncbi.nlm.nih.gov/pubmed/28180928">PubMed Abstract </a> | <a target=xrefwindow id=d66598e5364 href="http://dx.doi.org/10.1007/s00270-017-1593-5">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/729074385">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 04 Sep 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1637.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1637.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Medical Physiology, College of Medicine, Texas A&amp;M Health Science Center, Temple, TX, USA<br/> <sup>2</sup> Department of Internal Medicine, Baylor Scott &amp; White, Temple, TX, USA<br/> <sup>3</sup> Central Texas Veterans Healthcare System, Temple, TX, USA<br/> <p> <div class=margin-bottom> Victoria Liere <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Gurkarminder Sandhu <br/> <span>Roles: </span> Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Sharon DeMorrow <br/> <span>Roles: </span> Conceptualization, Funding Acquisition, Resources, Supervision, Writing – Original Draft Preparation, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-1637/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 04 Sep 2017, 6:1637 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.11938.1">https://doi.org/10.12688/f1000research.11938.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2017 Liere V <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=12904 data-id=11938 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11938.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-1637/v1/pdf?article_uuid=2c54ef11-67be-419d-b440-3ced39e29ece" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.11938.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Liere V, Sandhu G and DeMorrow S. Recent advances in hepatic encephalopathy [version 1; peer review: 4 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1637 (<a href="https://doi.org/10.12688/f1000research.11938.1" target=_blank>https://doi.org/10.12688/f1000research.11938.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=11938 id=mobile-track-article-signin-11938 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11938?target=/articles/6-1637.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12904 /> <input name=articleId type=hidden value=11938 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Don Rockey</strong>, Medical University of South Carolina, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Manuela Merli</strong>, Department of Clinical Medicine, Sapienza University of Rome, Italy </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Christopher Rose</strong>, University of Montreal, Canada </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Kevin Mullen</strong>, Case Western Reserve University, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 04 Sep 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1637.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1637.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=25429-25325></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=5680-25327></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=25428-25326></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=25430-25324></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=4><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> <th class="c-report-timeline__headings-version p-article__color--dark">4</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-1637/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>04 Sep 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Don Rockey</strong>, Medical University of South Carolina, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Manuela Merli</strong>, Department of Clinical Medicine, Sapienza University of Rome, Italy </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Christopher Rose</strong>, University of Montreal, Canada </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Kevin Mullen</strong>, Case Western Reserve University, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-1637.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-1637/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in hepatic encephalopathy".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-1637/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-1637/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-1637/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Liere V et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-1637/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-1637",
            templates : {
                twitter : "Recent advances in hepatic encephalopathy. Liere V et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-1637/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in hepatic encephalopathy", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in hepatic encephalopathy", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/11938/12904")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "12904");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "25324": 0,
                           "25325": 0,
                           "25326": 0,
                           "25327": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "bef93cad-b8c6-498c-b0af-449539d7e94d";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1637.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1637.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1637.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-1637.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-1637.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>